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Fluorine-19 (19F) magnetic resonance imaging (MRI) of the lungs using inhaled inert 
fluorinated gases can potentially provide high quality anatomical and functional images 
of the lungs. This technique is able to visualize the distribution of the inhaled gas, similar 
to hyperpolarized (HP) helium-3 (3He) and xenon-129 (129Xe) MRI. Inert fluorinated 
gases have the advantages of being nontoxic, abundant, and inexpensive compared to HP 
gases. Due to the high gyromagnetic ratio of 19F, there is sufficient thermally polarized 
signal for imaging, and averaging within a single breath-hold is possible due to short 
longitudinal relaxation times. Since inert fluorinated gases do not need to be 
hyperpolarized prior to their use in MRI, this eliminates the need for an expensive 
polarizer and expensive isotopes. Inert fluorinated gas MRI of the lungs has been studied 
extensively in animals since the 1980s, and more recently in healthy volunteers and 
patients with lung diseases.  
 
This thesis focused on the development of static breath-hold inert fluorinated gas MR 
imaging techniques, as well as the development functional imaging biomarkers in 
humans and animal models of pulmonary disease. Optimized ultrashort echo time (UTE) 
19F MR imaging was performed in healthy volunteers, and images from different gas 
breathing techniques were quantitatively compared. 19F UTE MR imaging was then 
quantitatively compared to 19F gradient echo imaging in both healthy volunteers and in a 
resolution phantom. A preliminary comparison to HP 3He MR imaging is also presented, 




gravitational gradients of ventilation in healthy volunteers. The potential of inert 
fluorinated gas MRI in detecting pulmonary diseases was further explored by performing 
ventilation mapping in animal models of inflammation and fibrosis. Overall, interest in 
pulmonary 19F MRI of inert fluorinated gases is increasing, and numerous sites around 
the world are now interested in developing this technique. This work may help to 
demonstrate that inert fluorinated gas MRI has the potential to be a viable clinical 
imaging modality that can provide useful information for the diagnosis and management 
of chronic respiratory diseases.  
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1.1 Clinical Motivation 
Respiratory diseases, such as asthma, cystic fibrosis (CF), chronic obstructive pulmonary 
disease (COPD), and interstitial lung disease (ILD), are a very significant world-wide 
health care burden. Chronic obstructive pulmonary disease (COPD) is associated with 
progressive and irreversible airflow limitation in the lung (1). COPD encompasses 
chronic bronchitis and emphysema, which represent airway obstruction and the 
enlargement of alveoli due to tissue destruction, respectively. COPD is currently one of 
the six leading causes of death in the United States, and death rates from COPD have 
been steadily increasing since 1970 (2). In Canada, approximately 4.4% of adults aged 35 
and over have COPD (~700,000 people), and this number very likely underestimates the 
true prevalence of COPD in Canada (3). On the global scale, COPD affects between 9 
and 10% of adults aged 40 and over (4). Asthma is associated with airway narrowing and 
airway wall inflammation in the lung (5). Like chronic bronchitis, asthma leads to airway 
obstruction and reduced ventilation in the lungs, however, this airway limitation is 
reversible with treatment (6). It has been estimated that asthma affects between 5 and 




Interstitial lung diseases (ILD) are a group of pulmonary disorders that affect the 
interstitial tissues in the alveoli, resulting in inflammation and fibrosis (8). A 20 year old 
epidemiological study estimated that ILD affects 80.9 per 100,000 men, and 67.2 per 
100,000 women in the United States (9). More recent studies have shown that the 
incidence and mortality of idiopathic pulmonary fibrosis (IPF), one type of ILD, is on the 
rise (10). Although these numbers seem low compared to COPD and asthma, the 
prognosis of ILD is generally very poor, as the root cause is sometimes unknown and the 
basic mechanisms are poorly understood.  
 
Given the substantial prevalence of respiratory diseases, numerous research efforts are 
currently underway that aim to help improve clinical outcomes. Unfortunately, a number 
of gaps have been identified in the care of pulmonary diseases, which can lead to an 
inadequate assessment of diagnosis and treatment progression (11). In other words, there 
is a problem in translating existing knowledge to routine clinical practice. Therefore, 
there is a significant need for new and effective methods to diagnose and manage 
respiratory diseases; these techniques should be relatively low-cost and easily translatable 
to clinical practice. 
 
1.2 Pulmonary Physiology 
The principal function of the lung is to permit gas exchange, where oxygen (O2) from the 
air is able to move into venous blood and carbon dioxide (CO2) is able to move out (12). 
The lung branches from the trachea into progressively narrower airways until the alveolar 
3 
 
ducts and alveolar sacs are reached. Figure 1-1 shows a diagram of the “airway tree” 
structure, with approximately 23 generations of branching between the trachea and 
alveoli (13). The first 15 generations are called the “Conducting Airways”; their purpose 
is to transport gas and they do not participate in gas exchange. The final 8 generations are 
called the “Acinar Airways”, which contain alveoli that participate in gas exchange 
through diffusive mechanisms. 
 
Figure 1-1: Weibel’s airway branching diagram. Image reproduced with permission (13). 
 
There are on average 480 million alveoli in the human lung (14) with a mean diameter of 
~200 μm (15). Overall, the total surface area available for gas exchange in the human 
lung is approximately 130 m2 (13), which is roughly half the size of a tennis court. Figure 
1-2 shows a micrograph from a human lung section, where the alveoli appear to have a 
4 
 
sponge-like structure and a terminal bronchiole clearly branches into respiratory 
bronchioles, alveolar ducts, and alveoli. 
 
Figure 1-2: Lung micrograph showing the structure of the alveoli and branching airways. Image 
reproduced with permission (13). 
 
The interested reader is referred to “Respiratory Physiology: The Essentials” by John B. 
West for more details on lung function, ventilation, and gas exchange (12). In addition, 
the companion volume “Pulmonary Pathophysiology: The Essentials” by John B. West 





1.3 Pulmonary Function Tests 
Pulmonary function tests (PFTs) are the current gold standard for the diagnosis and 
assessment of respiratory diseases such as COPD, CF, and asthma (17). One type of PFT 
is spirometry, which tests lung function by measuring airflow parameters as a function of 
time while a patient is either inhaling or exhaling through a tube (18). The volume of air 
that is exhaled in the first second of a forced expiration called the forced expiratory 
volume (FEV1), while the total volume exhaled is called the forced vital capacity (FVC) 
(12). The disease severity can then be evaluated with these parameters as well as ratios 
such as FEV1/FVC. For example, COPD is characterized by airflow limitation where 
both FEV1 and FVC are expected to decrease; however, FEV1 generally decreases more 
than FVC and therefore an FEV1/FVC ratio less than 0.7 is a typical threshold used to 
diagnose COPD (17). COPD is further classified into four stages according to the Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines (17). These stages 
are defined according to FEV1 as a percentage of the predicted value that is normalized 
based on demographic parameters such as age, sex, height, weight, etc.:  
 Stage I (mild) has an FEV1 of >80% of the predicted value, 
 Stage II (moderate) has an FEV1 between 50 and 80% of the predicted 
value, 
 Stage III (severe) has an FEV1 between 30 and 50% of the predicted value,  




Another type of PFT is body plethysmography, which is able to measure lung volumes 
while a patient is sitting inside an enclosed box (19). By measuring pressure changes 
inside the box during respiratory efforts, lung volumes can be calculated. Parameters of 
interest include the residual volume (RV), functional residual capacity (FRC), and total 
lung capacity (TLC). Figure 1-3 shows how these lung volumes relate to breathing 
manoeuvers that are performed during PFT measurements. The TLC is the total lung 
volume after a maximal inspiration, the FRC is the volume remaining after normal 
expiration, and the RV is the volume remaining after a maximal expiration.   
 
Figure 1-3: Lung volumes measured with PFTs. Adapted from (12). 
 
Other parameters include the vital capacity (VC), which is the volume exhaled following 
a maximal inspiration, and the tidal volume (TV), which is the volume change during a 




In addition to spirometry and plethysmography, other types of PFTs include helium 
dilution (20), multiple breath nitrogen wash-out (MBNW) (21), and the diffusing 
capacity of carbon monoxide (DLCO) (22). Although PFTs are considered to be the gold 
standard diagnostic tools, they do not provide any regional information with respect to 
lung function, whereas the distribution of lung function is well-known to be 
heterogeneous and largely driven by gravity (23). A number of non-invasive lung 
imaging techniques have been developed recently that may be able to provide critical 
functional and regional information that PFTs lack. Overall, these developments may 
help to improve the diagnosis and treatment of respiratory diseases.  
 
1.4 Conventional Lung Imaging Techniques 
The following sections briefly describe a number of non-invasive imaging techniques that 
can be used to study lung structure and function, including X-ray computed tomography 
(CT), single photon emission computed tomography (SPECT), positron emission 
tomography (PET), and magnetic resonance imaging (MRI). For more details on the 
physics of these imaging modalities, the interested reader is referred to “The Essential 
Physics of Medical Imaging” by Bushberg et al. (24). 
 
1.4.1 X-Ray Computed Tomography 
X-ray computed tomography (CT) of the lung has been performed since the 1970s and it 
still plays an important role in the diagnosis of respiratory diseases (25). A CT system 
consists of a rotating gantry mounted with an x-ray tube and detector system. 
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Transmission measurements are performed at many angles around the patient, and the X-
ray attenuation data is used to reconstruct a map of the tissue density. Tissue density is 
measured on a linear scale in Hounsfield units (HU), which is defined as zero for water, 
and -1000 for air (26). Therefore, high-density structures, such as bone, appear bright; 
while low density structures, such as the lungs, appear dark. 
 
Some of the first reports involving quantitative pulmonary CT were published by 
Hoffman et al. in the 1980s, and these studies examined the volume and shape of the 
lungs (27), gravitational gradients in the distribution of ventilation (28,29), the effects of 
orientation on lung expansion (28,29), and models for calculating the fractional air 
content (30). Pulmonary CT imaging has also been used to study airway narrowing and 
airway wall thickness in asthmatic subjects (31). CT is also able to quantify emphysema 
by measuring the fraction of the lung where air spaces have been enlarged due to tissue 
destruction (32). A threshold CT number is set, typically -950 HU, below which the 
tissue is considered emphysematous. Therefore, CT is able to phenotype COPD by 
identifying disease attributes through the measurement of image-based biomarkers (33). 
 
Stable xenon (Xe) gas can be used as a contrast agent in CT imaging to obtain functional 
information from the lung (34). Since Xe is non-radioactive and denser than air, the 
measured CT density is directly proportional to the Xe concentration. Dynamic lung 
imaging during Xe breathing cycles allows for the measurement of wash-in and wash-out 
characteristics (35), and this technique also permits the calculation of regional ventilation 
(36). The use of dual-energy CT allows for a direct visualization of the Xe distribution 
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without the registration artifacts that arise in methods that require a subtraction of 
enhanced and unenhanced images (37,38). Pulmonary perfusion can also be measured 
using dual-energy CT by injecting an iodine-based contrast agent (39). Ventilation and 
perfusion measurements obtained using dual-energy CT have been successfully validated 
with comparisons to SPECT and conventional CT (40). Recent studies have shown that 
dual-energy CT is able to provide clinically meaningful information that can be used to 
evaluate lung function in asthmatic subjects, and ventilation defect scores were shown to 
correlate with PFT parameters (41). 
 
Overall, CT has the ability to achieve a very high spatial resolution and it has the ability 
to obtain quantitative functional lung information. However, a significant disadvantage of 
CT is its use of ionizing radiation, which limits the potential for longitudinal studies, 
especially in children. The lung is a particularly radiosensitive organ, and the radiation 
dose delivered during a CT scan of the chest has historically been very high (42). Recent 
efforts have focused on reducing the CT radiation dosage through the development of 
novel reconstruction techniques (43) and efficient imaging protocols (44). CT will likely 
continue to be an important component of clinical pulmonary imaging; however, future 
developments in CT will have to leverage the quantitative and functional aspects against 





1.4.2 Nuclear Medicine 
Nuclear medicine refers to techniques that use radioactive tracers for diagnostic purposes, 
such as SPECT and PET. Both of these techniques can potentially be used to obtain 
functional lung information; however, the use of nuclear medicine in pulmonary imaging 
is not as ubiquitous as CT. In SPECT, the regional distribution of ventilation can be 
studied using the inhalation of technetium-99m (99mTc)-labelled graphite particles. This 
technique has been successfully used to study airflow limitation in patients with asthma 
(45) and emphysema (46). In addition to ventilation-related information, SPECT can also 
be used to measure the regional distribution of perfusion using an injection of indium-
113m (113mIn)-labelled albumin. The use of both radioactive tracers, 99mTc and 113mIn, 
allows for the measurement of the regional ventilation-perfusion ratio (V/Q), which is an 
important parameter in pulmonary physiology (47). V/Q is directly related to gas 
exchange, and a ratio of unity indicates a good “matching” between ventilation and 
perfusion in the lungs (12). On the other hand, V/Q ratios greater or less than 1 are 
indicative of gas exchange impairment and disease. 
 
Similar to SPECT, PET is an imaging modality that also requires the injection or 
inhalation of radioactive tracers. The isotopes used for PET imaging, such as 11C, 18F or 
15O, emit a positron through β+ decay. Once the positron encounters an electron, the two 
particles will annihilate and emit two gamma rays in opposite directions. The final PET 
image is then reconstructed from measurements of coincident photon detections. 
Numerous studies have used PET to investigate lung structure and function, including 
techniques that can determine the tissue volume, blood volume and alveolar gas volume 
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(48). PET can be used to assess regional ventilation by quantifying the wash-in and wash-
out of 13N gas (49). This method can help to identify air trapping in lung compartments 
that empty slowly. The injection of 13N dissolved in saline also enables the measurement 
of perfusion with PET, and the wash-out of the dissolved 13N can be used to calculate the 
V/Q ratio (50,51). These approaches have been used to study ventilation and perfusion in 
animals models of acute lung injury (52) and pulmonary embolism (53), as well as in 
humans with methacholine-induced bronchoconstriction (51).  
 
Like CT, nuclear medicine techniques also use significant levels of ionizing radiation, 
which limits longitudinal studies of lung function (54). Although PET and SPECT have a 
very high sensitivity, these techniques suffer from a relatively poor spatial resolution 
compared to CT (47). Furthermore, there are significant problems in the supply chain of 
radioactive isotopes (55). The National Research Universal nuclear reactor in Chalk 
River, Ontario produces a substantial fraction of the world’s supply of nuclear medicine 
isotopes, and shifting government priorities have led to an uncertain future for this 
facility. Therefore, there has been a renewed push to develop alternative methods for 
isotope production, including the use of cyclotrons. 
 
1.4.3 Magnetic Resonance Imaging 
MRI was first demonstrated by Paul Lauterbur in a 1973 Nature article (56). In this 
seminal publication, two-dimensional MR imaging was performed by applying magnetic 
field gradients to a conventional nuclear magnetic resonance (NMR) system. Crude 
images were obtained from water-filled capillaries placed inside a tube of heavy water.  
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In the presence of a magnetic field gradient, the NMR signal is essentially a one-
dimensional projection of the sample. A 2D image can then be reconstructed by applying 
back-projection techniques that are commonly used in CT imaging. Paul Lauterbur 
proposed that this technique be referred to as “zeugmatography”, meaning the joining of 
magnetic fields. For these discoveries, Paul Lauterbur won the Nobel Prize in 2003, 
shared with Peter Mansfield. Despite the fact that Paul Lauterbur’s moniker for this 
technique didn’t catch on, MRI has revolutionized medical imaging with its ability to 
provide images with high spatial resolution, good soft tissue contrast, and without the 
need for ionizing radiation. 
 
Conventional MRI is generally sensitive to thermally polarized hydrogen nuclei (often 
referred to as protons or 1H) in water molecules. (The physics of MRI will be discussed 
in greater detail in Sections 1.6 and 1.7.) Conventional 1H MRI of the lung has 
historically been very challenging, owing primarily to a low tissue density that yields a 
smaller signal than other proton-rich tissues (57). Pulmonary MRI is further confounded 
by high magnetic susceptibility differences at air/tissue interfaces, which leads to short 
transverse relaxation times and a short signal lifetime. Furthermore, respiratory and 
cardiac movement during imaging can lead to motion artifacts. As a result, the lungs 
generally appear to be a large black signal void in conventional 1H MR imaging.  
 
Figure 1-4 shows a comparison of conventional 1H MR lung images acquired in Thunder 
Bay, Ontario, from a healthy volunteer and a patient with severe COPD. In both of these 
cases, there is very little MRI signal from inside the lungs, other than the pulmonary 
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vasculature. The lungs are clearly enlarged in the COPD case, which is to be expected 
due to a loss of elastic recoil; however, these images in general show very little functional 
information inside the lungs that might give insight into which portions of the lung are 
actively participating in ventilation and gas exchange. 
 
Figure 1-4: Conventional 1H MR lung images acquired in (a) a healthy volunteer and (b) a patient with 
severe COPD. 
 
A number of novel and efficient 1H-based MRI acquisition strategies have been 
developed for lung imaging, such as balanced steady state free precession (SSFP) (58), 
ultrashort echo time (UTE) (59), zero echo time (ZTE) (60,61), and pointwise encoding 
time reduction with radial acquisition (PETRA) (62). These approaches, in combination 
with respiratory gating, can potentially mitigate all of the traditional shortcomings of 
conventional 1H lung MRI; however, the resulting images still provide mainly anatomical 
details rather than functional information. In spite of this potential disadvantage, these 
1H-based MRI acquisition techniques may still have potential clinical applications, since 
it has been shown that UTE signal intensity is reproducible, related to tissue density (63), 




1.5 Functional Approaches to Pulmonary MRI 
 
1.5.1 1H MRI 
O2-enhanced (OE) 
1H lung MRI is a functional technique that is able to provide 
ventilation-related information by taking advantage of the 1H signal enhancement that 
results from inhaling pure O2. Since molecular O2 is paramagnetic, it tends to shorten the 
longitudinal relaxation of 1H in the body and therefore, inhaled O2 can serve as a contrast 
agent in pulmonary 1H MRI. By subtracting an unenhanced MR image obtained during 
normal air breathing, the resulting signal enhancement is related to the distribution of 
ventilation. In patients with lung cancer and emphysema, OE MRI is able to detect 
ventilation defects, which are signal voids that indicate unventilated regions of the lung 
(65,66). Results from OE MRI have also been shown to agree with nuclear medicine 
imaging techniques (65).  
 
Dynamic imaging during alternating breathing cycles of air and O2 can be used to 
investigate wash-in, wash-out and air trapping (67). A model describing the O2 wash-
in/wash-out kinetics can be used to compute a map of regional ventilation, and this 
technique yields the expected gravitational gradient in ventilation (68). Regional V/Q 
ratio measurements have also been demonstrated with 1H MRI using a combination of 
three techniques: OE MRI to measure specific ventilation, a modified arterial spin 
labelling (ASL) approach to measure perfusion, and a fast gradient echo method to 
measure regional lung density (69). This technique has been used to investigate posture-
dependent gradients in the V/Q ratio.  
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OE MRI can potentially be used to assess pulmonary diseases such as CF, since the 
resulting images are sensitive to ventilation heterogeneity and changes in tissue density 
(70). OE MRI has the advantage of being able to be performed on virtually any MRI 
scanner, and O2 is a readily available and inexpensive contrast agent. Unfortunately, OE 
MRI has a few potential disadvantages, and in particular, the O2-induced signal 
enhancement is very small. It may be possible to improve the quality of OE MRI with 
efficient acquisition strategies, such as UTE, but OE MRI may still suffer from a mis-
alignment of enhanced and unenhanced images (i.e. misregistration) (71). Furthermore, it 
is also unclear whether the O2-enhancement truly represents ventilation of the air spaces, 
since the signal change arises from interactions between 1H in tissue and O2 (57). 
 
Fourier decomposition (FD) is another 1H-based MRI technique that is able to obtain 
functional lung information without the use of a contrast agent (72). This method rapidly 
acquires free-breathing images at a rate of 3.33 images s-1. Since no form of gating is 
used during image acquisition, a non-rigid registration algorithm is required to 
compensate for respiratory motion. A pixel-by-pixel FD of the signal intensity yields 
spectral peaks corresponding to cardiac and respiratory frequencies, allowing for the 
calculation of perfusion- and ventilation-weighted images. FD MRI has been shown to be 
reproducible (73), and it has also been validated with a comparison to SPECT and CT 
imaging in porcine lungs (74).  
 
FD MRI has been successfully used to image a porcine model of pulmonary embolism 
(75), and recent work in human lungs has demonstrated the expected ventilation defects 
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in COPD (76). Ultra-fast SSFP techniques have recently been applied to FD MRI, and 
significantly improved image quality has been demonstrated (77). Like OE MRI, this 
technique can be performed on virtually any MRI scanner; however, FD MRI also has a 
few potential limitations. For example, FD MRI is an indirect method for the acquisition 
of ventilation and perfusion information. That is, the ventilation and perfusion related 
“signal” essentially arises from the regional change in 1H density due to the motion of the 
chest, and this technique cannot directly image the air space of the lung or blood flow. 
 
1.5.2 Hyperpolarized Noble Gas MRI 
The advent of hyperpolarized (HP) noble gas MRI, using helium-3 (3He) and xenon-129 
(129Xe), has substantially improved the ability of MRI to measure anatomical and 
functional changes in the lung due to disease progression and response to therapy. HP gas 
MRI of the lung was first demonstrated by Albert et al. in a 1994 Nature publication, 
where HP 129Xe imaging was performed in excised mouse lungs at 9.4 T (78). HP gas 
MRI can overcome the limitations of conventional 1H lung MRI by directly visualizing 
the distribution of the inhaled gases (79). Since 1994, various research groups around the 
world have performed HP 3He and 129Xe MRI studies in the lungs of animals (80-82) and 
humans (83-87). 
 
In conventional 1H MRI, the signal arises from a net magnetization due to a small 
population difference of nuclear spins in the presence of an externally applied magnetic 
field. This population difference is referred to as thermal polarization, and 1H has a 
polarization of approximately 9.9 x 10-6 at body temperature and in a clinical magnetic 
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field strength of 3 T. (Thermal polarization is quantitatively defined in section 1.6.2.) In 
HP gas MRI, 3He or 129Xe is pre-polarized outside of the imaging system, yielding a 
polarization that is 4 – 5 orders of magnitude greater than thermal equilibrium levels (88). 
Therefore, the available polarization in HP gas MRI is independent of the imaging field 
strength (89). The hyperpolarization process generally uses a non-equilibrium optical 
pumping technique, called spin-exchange optical pumping (SEOP) (90). Other 
hyperpolarization techniques include dynamic nuclear polarization (DNP) (91) and 
metastability exchange optical pumping (MEOP) (92); however, it should be noted that 
MEOP can only be used to hyperpolarize 3He. 
 
The SEOP process begins with circularly polarized laser light that is absorbed by an 
alkali metal vapour, such as Rubidium (Rb) (90). The circularly polarized laser light 
excites specific Rb electronic transitions, and the Rb becomes polarized. The angular 
momentum is then transferred to the noble gas nuclei by collisions. This process is 
typically performed at high pressure (up to 10 atm) and in the presence of a magnetic 
field (~a few mT). 129Xe is efficiently polarized at low partial pressure (1 – 3%) and in a 
continuous flow mode, while pure 3He is typically polarized in a batch mode for several 
hours inside a sealed glass vessel. Literature values for the final gas polarization vary 
considerably depending on the instrumentation as well as temperature and pressure 
parameters; however, 3He and 129Xe polarization values up to 50% are typical. Once 
polarized, imaging can be performed on an MRI scanner that has broadband multinuclear 
capabilities (i.e. the system can detect nuclei other than 1H) and dedicated 3He/129Xe 
radio frequency (RF) coils. 
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HP gas MRI has been used to visualize the lung air spaces in humans with a high degree 
of reproducibility (93), and image-derived biomarkers show a good correlation with PFTs 
(94), OE MRI (71) and FD MRI (75,76). HP gas MRI has also been successfully 
compared to established CT ventilation metrics (95), and it has been shown that HP gas 
MRI can potentially provide additional functional information that cannot be obtained 
from CT (83,96). HP gas MR image-derived biomarkers have the ability to phenotype 
respiratory diseases, and these measurements have been extensively used to investigate 
diseases such as asthma (97), COPD (83) and CF (98,99). For example, Figure 1-5 shows 
HP 3He MR images that were obtained in Thunder Bay, Ontario from a healthy volunteer 
and three patients with pulmonary diseases: asthma, moderate COPD, and severe COPD.  
 
Figure 1-5: HP 3He MR images acquired from four individuals: (a) healthy, (b) asthma, (c) moderate 
COPD, and (d) severe COPD. Images were reproduced with permission (100). 
 
The HP 3He signal is relatively homogeneous in the healthy volunteer, although there is 
some structure inside the lungs due to the pulmonary vasculature. Similar to OE MRI and 
FD MRI, ventilation defects can be observed in patients with pulmonary diseases, which 
are signal voids that indicate the presence of airway obstructions and unventilated lung 
regions. By co-registering HP gas images with a conventional 1H lung image, the total 
ventilated volume (VV), ventilation defect volume (VDV) and ventilation defect percent 
(VDP) can be measured (101). It has been demonstrated that these metrics can potentially 
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help to evaluate the severity of COPD, which makes this a very sevsitive technique for 
diagnostic purposes (102). 
 
In addition to static breath-hold ventilation imaging, HP gas MRI can also be used to 
obtain functional information from the lung, such as the measurement of the apparent 
diffusion coefficient (ADC), which has been correlated with tissue destruction and 
emphysema (103-105). By measuring changes in longitudinal relaxation due to the 
presence of O2, the regional alveolar partial pressure of O2 (PAO2) can be probed (106-
108). Air trapping and the distribution of ventilation dynamics can be assessed by 
acquiring multiple images at a high temporal resolution throughout a single inspiration, 
breath-hold and forced expiration (96). These studies have quantified the heterogeneous 
nature of obstructive lung diseases, demonstrating that HP gas MRI has the ability to 
provide regional information that is not available from traditional PFTs. Measurements of 
the regional V/Q ratio obtained from HP gas MRI have the potential to yield a greater 
spatial resolution than what is currently achievable with SPECT and PET (109). Overall, 
HP 3He and 129Xe MRI have the ability to obtain anatomical and functional information 
from the lungs using a non-invasive technique that does not require ionizing radiation. 
 
1.5.3 Inert Fluorinated Gas MRI 
The first demonstration of gas phase MRI was reported in the 1980s by Edwin 
Heidelberger and Paul Lauterbur, where pulmonary fluorine-19 (19F) MR imaging was 
performed using tetrafluoromethane (CF4). Heidelberger and Lauterbur were able to 
acquire crude images in phantoms, excised rabbit lungs (110), and in healthy dog lungs 
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(111,112) at a field strength of 0.1 T. 19F MR images were obtained during a 25 minute 
acquisition that resulted in a 65 x 65 x 65 matrix with a resolution of 2 – 3 mm. Unlike 
HP gases, inert fluorinated gases are imaged without hyperpolarization, which leads to an 
inherently lower signal-to-noise ratio (SNR). Therefore, little progress was made in the 
development of inert fluorinated gas MRI for many years, as investigators focused on 
developing HP gas MRI.  
 
In 1998, Kuethe et al. demonstrated high resolution 3D 19F MR imaging of rat lungs, and 
images were obtained during continuous breathing of a mixture of hexafluoroethane 
(C2F6) and O2 (113). These images had an isotropic resolution of 700 μm, and the 
acquisition took 4.3 hours to complete. It is interesting to note that Kuethe et al. used an 
image acquisition approach that was very similar to Paul Lauterbur’s original 
demonstration of MRI in 1973, except the image reconstruction used a 3D inverse 
Fourier transform rather than a back projection approach (56). In the same 1998 paper, 
Kuethe et al. hypothesized that human lung imaging with inert fluorinated gas MRI 
would be possible with a similar SNR efficiency as 1H MRI. This hypothesis was based 
on two assumptions: that the short longitudinal relaxation of fluorinated gases allows for 
more averaging than 1H MRI, and a relatively coarse matrix size of 64 x 64 would 
increase the number of 19F nuclei per voxel (113).  
 
Inert fluorinated gas MRI of human lungs was first demonstrated by Wolf and Schreiber 
et al., and this work was reported at the 2008 annual meeting of the International Society 
for Magnetic Resonance in Medicine (ISMRM) (114). In this brief report, 2D whole lung 
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projection images were acquired in a healthy volunteer using a mixture of sulfur 
hexafluoride (SF6) and O2. These initial images were rather poor in quality, and the SNR 
was approximately 9. This low SNR was perhaps due to the exceedingly short transverse 
relaxation of SF6 in the lungs. Nevertheless, this initial human imaging work was an 
important benchmark that opened the doors to new developments in this lung imaging 
modality.  
 
In 2013, inert fluorinated gas 3D UTE MRI was reported in healthy volunteers (115). 
Figure 1-6 shows a comparison of conventional 1H MRI and 19F 3D UTE MRI acquired 
in the lungs of a healthy volunteer. This imaging was performed under breath-hold 
conditions, following several breaths of a mixture of 79% perfluoropropane (PFP) and 
21% O2. Similar to HP gas MRI, the 
19F signal is fairly bright and homogeneous 
throughout the lungs of this healthy volunteer. This work was performed at the Thunder 
Bay Regional Research Institute (TBRRI) in Thunder Bay, Ontario, and it represents the 
major focus of this thesis. Chapters 2 through 5 discuss the development of inert 
fluorinated gas MRI in Thunder Bay, Ontario, including imaging performed in both 




Figure 1-6: Comparison of centre slice 1H localizer and 19F UTE images acquired in the coronal and axial 
planes. 
 
In 2013, 3D inert fluorinated gas MRI was also reported in patients with COPD, asthma, 
and post-lung transplantation (116). This work was performed by Halaweish and Charles 
et al. at Duke University, and the same inhaled gas mixture of 79% PFP and 21% O2 was 
used. Figure 1-7(a) shows an example of 3D 19F MR imaging in the lungs of a COPD 
patient with emphysema. Although the image quality was rather poor, Halaweish et al. 
showed that inert fluorinated gas MRI has the ability to detect ventilation defects in 
patients with COPD, in a manner that is similar to HP gas MRI. Figure 1-7(b) shows the 
same 3D 19F MR image overlaid in greyscale on a conventional 1H MR image. Similar to 
HP gas MRI, this approach can be used to analyze volumetric parameters, such as the 




Figure 1-7: (a) Coronal 19F 3D MR images obtained in a COPD patient with emphysema. (b) 19F MR lung 
images overlaid in greyscale on conventional 1H MR images. Images were reproduced with permission 
from Halaweish et al. (116). 
 
Halaweish et al. also developed a custom-built MR-safe gas delivery system to deliver 
the PFP/O2 mixture to subjects (117). The computer-controlled delivery system was able 
to switch between air, O2, and the fluorinated gas mixture, as well as provide additional 
information in real-time, such as heart rate, O2 saturation, O2/CO2 concentration, and 
flow rate. Ideally, a robust gas delivery system can potentially improve patient 
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compliance, repeatability, as well as provide additional information to aid in the 
interpretation of inert fluorinated gas images.  
 
Overall, the work to date has demonstrated that inert fluorinated gas MRI is a safe and 
well-tolerated technique (118), and that it can be performed in volunteers and patients 
with severe pulmonary diseases. Like HP gas MRI, inert fluorinated gas MRI can be 
performed on any MRI scanner that has broadband multinuclear capabilities and 
dedicated RF coils. Moving forward, researchers will focus on validating inert fluorinated 
gas MRI with rigorous comparisons to existing diagnostic techniques, such as HP gas 
MRI, CT, and PFTs. This work will help to determine if inert fluorinated gas MRI is able 
to provide clinically meaningful information that can benefit individuals with pulmonary 
diseases.  
 
1.6 Nuclear Magnetic Resonance 
In order to facilitate a discussion of MRI acquisition techniques for pulmonary imaging 
in this thesis, the basic principles of nuclear magnetic resonance (NMR) are described in 
this section, including the nuclear magnetic moment, magnetization, precession in a static 
magnetic field, precession in a time-varying magnetic field, spin-lattice relaxation, and 
spin-spin relaxation. Section 1.7 will continue this discussion, by introducing spatial 
localization and image formation principles. For more details on the physics of NMR, 
MRI, and image formation, the interested reader is referred to “Magnetic Resonance 
25 
 
Imaging: Physical Principles and Pulse Sequence Design” by Haacke et al. (119) and 
“Principles of Magnetic Resonance Imaging” by Dwight G. Nishimura (120). 
 
1.6.1 Nuclear Magnetic Moment 
NMR arises from nuclei with an odd number of protons and/or neutrons. Such nuclei 
possess spin angular momentum, which is given by: 
 𝐽 = ℏ𝐼, [1-1] 
where ℏ is the reduced Planck’s constant, and I is the intrinsic half-integer spin. The spin 
angular momentum causes the nucleus to behave like a spinning charge, which gives rise 
to a magnetic dipole moment: 
 ?⃗? = 𝛾𝐽 = 𝛾ℏ𝐼, [1-2] 
where 𝛾 is the gyromagnetic ratio, which is unique to each nucleus and characterizes the 
ratio of the magnetic dipole moment to the spin angular momentum. The gyromagnetic 
ratios for a few spin-½ nuclei of interest are shown in Table 1-1. Nuclei that have a spin 
greater than ½ can also be NMR-sensitive, such as 83Kr and 131Xe, however these nuclei 
have a quadrupole moment that leads to relaxation properties that are not ideal for lung 
imaging (121). 
Table 1-1: Gyromagnetic ratios of a few NMR-sensitive nuclei (122). 
Nucleus Spin, I 𝛾 [MHz·rad·T-1] 𝛾 2𝜋 ⁄ [MHz·T-1] 
1H ½ 267.519 42.577 
3He ½  -203.814 -32.438 
13C ½ 67.280 10.708 
19F ½ 251.818 40.078 




When placed in an external magnetic field, spins tend to align with the magnetic field, 
thus giving rise to a net magnetization density: 





where ∆𝑉 is a volume of interest. From a classical perspective, this net magnetization, ?⃗⃗⃗?, 
can simply be interpreted as a vector sum of all the magnetic dipole moments in a 
sample. A schematic of the net magnetization vector is shown in Figure 1-8 for an 
external magnetic field, B0, that points in the positive z-direction. 
 
Figure 1-8: Net magnetization of an ensemble of nuclear spins. 
A more rigorous treatment from a quantum mechanical perspective will show that the net 
magnetization vector actually arises from a population difference in energy levels. First, 
consider the potential energy of a magnetic dipole moment in the presence of a magnetic 
field, which is defined as the following: 








Using Eq. [1-2], the potential energy can be rewritten to include the spin and 
gyromagnetic ratio in the following way: 
 𝐸 = −𝛾ℏ𝐼𝐵0. [1-5] 
Since spin-½ nuclei can exist in either a “spin-up” or “spin-down” state, the spin has a 
value of 𝐼 = + 1 2⁄  or 𝐼 = − 1 2⁄ . Therefore, these states are separated by the following 
quantity of potential energy: 
 ∆𝐸 =  𝛾ℏ𝐵0, [1-6] 
where the lower energy state is aligned parallel to the magnetic field, and the higher 
energy state is aligned anti-parallel to the magnetic field. This phenomenon is known as 
the Zeeman effect (119).  
 
At thermal equilibrium, there will be a slight excess of spins in the 𝐼 = + 1 2⁄  state, 






where 𝑁↑ is the number of spins aligned with the magnetic field and 𝑁↓ is the number of 
spins aligned against the magnetic field. This situation is shown in Figure 1-9 for an 
ensemble of nuclear spins placed inside a magnetic field, B0, and there is a slight excess 




Figure 1-9: Thermal polarization of an ensemble of nuclear spins. 
 
The polarization in Eq. [1-7] can interpreted as a probability of alignment with the 
magnetic field, and it can be quantified using the Boltzmann distribution, 𝑒−𝐸 𝑘𝑇⁄ , in the 
following way: 
 𝑃 =
𝑒𝜇𝐵0 𝑘𝑇⁄ − 𝑒−𝜇𝐵0 𝑘𝑇⁄








Since 2𝑘𝑇 is typically much greater than ℏ𝛾𝐵0, the polarization in Eq. [1-8] can be 





If there is no external magnetic field, then the two spin states are degenerate. That is, 
there is an equal probability of being in either state, leading to a net polarization of zero. 
At body temperature and in a clinical magnetic field strength of 3 T, the polarization of 
1H is approximately 9.9 x 10-6. Although this polarization is very small, MR imaging is 




In general, the net magnetization can be related to polarization in the following way:  
 𝑀 = 𝑁𝑉 ∙ 𝜇 ∙ 𝑃, [1-10] 
where 𝑁𝑉 is the number of magnetic dipole moments per unit volume. A final expression 
for the net magnetization of spin-½ nuclei can be derived by inserting Eqs. [1-2] and 
[1-9] into Eq. [1-10]: 











where 𝑀0 refers to the thermal equilibrium magnetization. 
 
As noted in Section 1.5.2, HP gas MRI uses 129Xe or 3He that has been pre-polarized 
outside of the imaging system via SEOP. The polarization of 129Xe or 3He can reach 4 – 5 
orders of magnitude greater than thermal equilibrium, which yields a greater 
magnetization density according to Eq. [1-10] and hence a greater MRI signal (88). 
Therefore, HP media represent a unique case where Eqs. [1-8], [1-9], and [1-11] do not 
apply. Figure 1-9 shows a schematic diagram of a non-equilibrium hyperpolarized 
situation, where a much larger fraction of the spins are in the lower energy state and 
aligned with the magnetic field, B0. 
 




1.6.3 Precession in a Static Magnetic Field 
At thermal equilibrium, nuclear magnetic moments tend to align with the magnetic field 
and the net magnetization, ?⃗⃗⃗?, points in the same direction as ?⃗⃗?0. If the magnetic 
moments are perturbed away from the direction of ?⃗⃗?0, then they will experience a torque, 
given by the following expression:  
 𝜏 = ?⃗? × ?⃗⃗?0. [1-12] 
By noting that torque is equal to the time derivative of angular momentum, Eq. [1-12] 




𝐽 = ?⃗? × ?⃗⃗?0. [1-13] 
Multiplying Eq. [1-13] by the gyromagnetic ratio, γ, and inserting Eq. [1-2] yields the 




?⃗? = ?⃗? × 𝛾?⃗⃗?0. [1-14] 
The nuclear magnetic moment, ?⃗?, in Eq. [1-14] can be replaced by the net magnetization, 




?⃗⃗⃗? = ?⃗⃗⃗? × 𝛾?⃗⃗?0. [1-15] 
Assuming ?⃗⃗?0 points in the positive z-direction, the differential equation can be solved to 
describe the behaviour of the net magnetization vector:  
 𝑀𝑥𝑦 = (𝑀0 sin 𝜃) ∙ 𝑒
−𝑖𝜔0𝑡,   𝑀𝑧 = 𝑀0 cos 𝜃, [1-16] 
where 𝑀𝑥𝑦 is a rotating vector in the xy-plane composed of 𝑀𝑥 + 𝑖𝑀𝑦, 𝑀𝑧 is the 
component in the positive z-direction, and θ is the polar angle. Overall, Eq. [1-16] implies 
31 
 
that the net magnetization vector precesses about the magnetic field lines at a frequency 
of 𝜔0. The precessional frequency is also referred to as the Larmor frequency, and it can 
be calculated using the Larmor equation: 
 𝜔0 = −𝛾𝐵0. [1-17] 
Since γ is unique to each nucleus (see Table 1-1), it can be seen from Eq. [1-17] that each 
nucleus has a unique precessional frequency. The negative factor implies that for positive 
γ, the magnetization precesses clockwise. 
 
1.6.4 Precession in a Time-Varying Magnetic Field 
An NMR signal can be obtained by applying a radio frequency (RF) pulse to a sample. 
When the RF pulse is applied, there is an additional time-varying magnetic field, denoted 
as ?⃗⃗?1, in a direction perpendicular to the main magnetic field. In general, ?⃗⃗?1 is a rotating 
vector in the xy-plane:  
 𝐵𝑥𝑦 = |?⃗⃗?1| ∙ 𝑒
−𝑖𝜔𝑡, [1-18] 
where 𝜔 is the angular frequency of the RF pulse. Since ?⃗⃗?1 is a rotating vector, it is 
convenient to transform the coordinate system to a reference frame rotating about the z-
direction at a frequency 𝜔. The total effective field in the rotating reference frame can be 
described by the following expression: 
 ?⃗⃗?𝑒𝑓𝑓 = 𝐵1𝑖̂ + (𝐵0 −
𝜔
𝛾
) ?̂?, [1-19] 
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where the ?⃗⃗?1 field appears stationary along the x-direction, and the longitudinal 
component appears reduced. If the RF pulse is rotating at exactly the Larmor frequency, 
then the effective field can be simplified in the following way: 
 ?⃗⃗?𝑒𝑓𝑓 = 𝐵1𝑖̂ + (𝐵0 −
𝜔0
𝛾
) ?̂? = 𝐵1𝑖̂. [1-20] 
Therefore, the behaviour of the net magnetization vector during an RF pulse can be 




?⃗⃗⃗? = ?⃗⃗⃗? × 𝛾?⃗⃗?𝑒𝑓𝑓 = ?⃗⃗⃗? × 𝛾𝐵1𝑖̂, [1-21] 
where a solution this differential equation would show that the net magnetization vector 
precesses about the 𝐵1 field in a clockwise fashion at the following frequency: 
 𝜔1 = −𝛾𝐵1. [1-22] 
The angle at which the net magnetization vector is rotated away from the z-direction by 
the RF pulse is referred to as the flip angle. This angle is equal to the magnitude of Eq. 
[1-22] integrated with respect to time: 
 𝜃1 = ∫ |𝜔1|
𝜏
0




After an RF pulse of flip angle 𝜃 has been applied, the components of the magnetization 
vector have the following magnitudes: 
 |𝑀𝑥𝑦| = 𝑀0 sin 𝜃 , |𝑀𝑧| = 𝑀0 cos 𝜃. [1-24] 
A schematic diagram of this process is shown in Figure 1-11, where a 90º RF pulse has 
been applied and the net magnetization has been rotated 90º clockwise about the ?⃗⃗?1 




Figure 1-11: Application of a 90º RF pulse in a rotating reference frame (x', y', z'). 
 
After the RF pulse is turned off, the net magnetization vector continues to precess about 
the main magnetic field, 𝐵0, according to Eq. [1-16]. A signal can be detected in the RF 
coil, since the precessing magnetization produces a changing magnetic flux, Φ, in the 
coil. Since the RF coil is oriented perpendicular to the main magnetic field, only the 
transverse component of the magnetization vector, 𝑀𝑥𝑦, will induce a signal response. 
From Eq. [1-24], it can be seen that a 90º RF pulse will yield the highest possible signal.  
 
The detected NMR signal is called a free induction decay (FID), and the electromotive 
force induced in the coil is given by Faraday’s law:  
 𝑆(𝑡) = −
𝑑
𝑑𝑡
Φ(𝑡) = − ∫ 𝑑𝑉 (
𝑑
𝑑𝑡
?⃗⃗⃗?(𝑟, 𝑡)) ∙ ?⃗⃗?1
𝑉𝑠
(𝑟), [1-25] 
where 𝑆(𝑡) is the received signal in units of volts, ?⃗⃗⃗?(𝑟, 𝑡) is the magnetization density in 
the transverse plane at a position 𝑟, ?⃗⃗?1(𝑟) is the magnetic field produced by the RF coil at 









is a rotating vector of the form  ?⃗⃗⃗?(𝑟) ∙ 𝑒−𝑖𝜔0𝑡, the MRI signal that is received in the RF 
coil can be rewritten without the explicit time derivative:  
 𝑆(𝑡) = 𝑖𝜔0𝑒
−𝑖𝜔0𝑡 ∫ 𝑑𝑉 ∙ ?⃗⃗⃗?(𝑟) ∙ ?⃗⃗?1
𝑉𝑠
(𝑟). [1-26] 
After the magnetization vector has been perturbed from equilibrium by an RF pulse, the 
magnetization component in the transverse plane decays via spin-spin relaxation, while 
the magnetization component in the longitudinal direction re-grows via spin-lattice 
relaxation. Thus, the net magnetization vector eventually returns to equilibrium. These 
relaxation mechanisms are described in detail in Sections 1.6.5 and 1.6.6, and they will 
provide additional factors that affect the received signal that was defined in Eq. [1-26]. 
 
1.6.5 Spin-Lattice Relaxation 
Spin-lattice relaxation refers to the return to thermal equilibrium along the longitudinal 
direction. An RF pulse stimulates transitions between the energy states described in 
Figure 1-9, where the difference between the energy levels is given by ∆𝐸 =  𝛾ℏ𝐵0. The 
system relaxes via interactions with rapidly fluctuating magnetic fields caused by the 
motion of magnetic dipoles. These time-dependent magnetic fields have frequencies 
close to 𝛾𝐵0, causing transitions between the energy states, and returning the system to 











where 𝑀𝑧 is the longitudinal component of the magnetization, 𝑀0 is the thermal 
equilibrium magnetization, and T1 is the longitudinal relaxation time constant. Equation 
[1-27] has the following general solution:  
 𝑀𝑧(𝑡) = 𝑀(0)𝑒
−𝑡 𝑇1⁄ + 𝑀0(1 − 𝑒
−𝑡 𝑇1⁄ ), [1-28] 
where 𝑀(0) is the longitudinal magnetization at zero time. If a 90° RF pulse is applied to 
the sample, then it can be assumed that 𝑀(0) = 0, and therefore, the magnetization re-
grows to thermal equilibrium according to the following: 
 𝑀𝑧(𝑡) = 𝑀0(1 − 𝑒
−𝑡 𝑇1⁄ ). [1-29] 
The behaviour of the longitudinal magnetization following a 90° RF pulse is shown in 
Figure 1-12 for three different T1 values: 10 ms, 250 ms, and 1000 ms.  
 




A general rule of thumb states that after a duration of 5·T1, the longitudinal 
magnetization has recovered approximately to thermal equilibrium. Since T1 can be a 
function of position, it will be an important factor in determining image quality and 
contrast. Thus, the signal equation from the preceding section can be modified to include 
the effects of T1: 
 𝑆(𝑡) = 𝑖𝜔0𝑒




The exponential re-growth of longitudinal magnetization applies to conventional 1H MRI 
and inert fluorinated gas MRI; however, a few special considerations are required for HP 
gas MRI. Since HP gases initially have a magnetization that is 4 – 5 orders of magnitude 
greater than thermal equilibrium levels, the first term in Eq. [1-28] dominates, and the 
relaxation of the longitudinal magnetization is effectively an exponential decay with a 
time constant of T1. The T1 of HP gases is environment-dependent, and it can vary from 
several hours in a strong homogeneous magnetic field to 10s of seconds inside the lungs. 
Following the application of an RF pulse, the hyperpolarized magnetization does not 
return to its initially high value. Instead, the longitudinal magnetization continues to 
decay toward the much smaller 𝑀0 at a rate of 1 𝑇1⁄  as indicated by Eq. [1-28].  
 
1.6.6 Spin-Spin Relaxation 
Spin-spin relaxation refers to the decay of the magnetization component in the transverse 
plane. The mechanism for this relaxation is local dipolar interactions, which cause local 
variations in the z-component of the magnetic field. This leads to a broadening in the 
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resonance frequency and hence, a dephasing of the transverse magnetization. The decay 








where 𝑀𝑥𝑦 is the magnetization in the transverse plane, and 𝑇2 is the transverse 
relaxation time constant. Equation [1-31] has the following solution:  
 𝑀𝑥𝑦(𝑡) = 𝑀(0)𝑒
−𝑡 𝑇2⁄ , [1-32] 
where 𝑀(0) is the initial transverse magnetization immediately following the RF pulse. 
The decay of transverse magnetization following a 90° RF pulse is shown in Figure 1-13 
for three different T2 values: 2 ms, 10 ms, and 100 ms. The T2 values shown in Figure 
1-13 are less than the T1 values shown in Figure 1-12, and generally speaking, T2 is 
always less than or equal to T1. 
 




The apparent transverse relaxation time, T2
∗, is shorter than T2, since it includes additional 














where T2 is the inherent transverse relaxation due to dipolar interactions, T2′ is the 
transverse relaxation due to static magnetic field inhomogeneities, and T2,susc is the 
transverse relaxation due to differences in the magnetic susceptibility of the sample. It 
should also be noted that diffusion plays a role in modulating spin-spin relaxation arising 
from magnetic susceptibility differences. The signal expression from Eq. [1-30] can be 
modified to include T2
∗ effects in the following way: 
 𝑆(𝑡) = 𝑖𝜔0𝑒




Similar to the T1 effects described in Section 1.6.5, the T2
∗ can vary as a function a 
position, which can provide a source of image contrast. Furthermore, the T1 and T2 
effects can be incorporated into Eq. [1-15] in order to fully describe the dynamics of the 











The x-, y-, and z-components of Eq. [1-35] are often referred to as the phenomenological 




1.7 Magnetic Resonance Imaging 
Building on the NMR physics that was introduced in Section 1.6, this section describes 
the MRI physics of spatial localization and image formation. Spatial localization is first 
described in general terms, followed by more specific discussions of the MRI data 
acquisition techniques used in this thesis, including gradient echo imaging, UTE imaging, 
and x-centric imaging. This section also briefly discusses some SNR considerations that 
are important for comparing the image quality between different MRI acquisitions.  
 
1.7.1 Spatial Localization 
In order to acquire an MR image, the received signal must be spatially localized by 
applying linear gradient magnetic fields in addition to 𝐵0. The net magnetic field points 
in the z-direction, with spatial variations in the x-, y-, or z-directions: 







 and 𝐺𝑧 =
𝑑𝐵𝑧
𝑑𝑧
. In general, magnetic field gradients can be time-
varying, they can be a function of position, 𝑟, and the combined magnetic field gradient 
can be written as a single vector in the following way: 














The application of a magnetic field gradient has the effect of adding an additional linear 
phase factor to the signal equation: 
 
𝑆(𝑡) = 𝑖𝜔0𝑒






where the phase accumulated during the application of a magnetic field gradient is 
defined by the following:  









∫  𝑑𝑡′ ∙ ?⃗?(𝑡′)
𝑡
0
, such that ∆𝜑(𝑟, 𝑡) = 2𝜋(?⃗⃗? ∙ 𝑟). [1-40] 
Therefore, k-space can be interpreted as a conjugate space where the position in k-space 
characterizes the amount of phase accumulated by magnetization during the application 
of magnetic field gradients. Alternatively, k-space can be interpreted as containing 
information related to spatial frequencies. 
 
The basic objective of spatial localization is to use the received signal to recover a map of 
the magnetization density, which is inherently modulated by relaxation, the ?⃗⃗?1 field of 





For the purposes of this discussion, consider an effective magnetization density that 
incorporates these relaxation, ?⃗⃗?1, and phase effects: 
 ?̂?(𝑟) = 𝑖𝜔0𝑒
−𝑖𝜔0𝑡 ∙ ?⃗⃗⃗?(𝑟) ∙ (1 − 𝑒−𝑡 𝑇1(𝑟)⁄ ) ∙ 𝑒−𝑡 𝑇2
∗(𝑟)⁄ ∙ ?⃗⃗?1(𝑟). [1-41] 
Inserting Eqs. [1-40] and [1-41] into [1-38] yields the following signal equation: 
 𝑆(?⃗⃗?) = ∫ 𝑑𝑉 ∙ ?̂?(𝑟)
𝑉𝑠
∙ 𝑒−𝑖2𝜋(?⃗⃗?∙𝑟), [1-42] 
where the received signal is now a function of the position in k-space and integrated over 
all of image space. Following data acquisition, with a sufficiently sampled k-space, the 
effective magnetization density can be recovered by performing an inverse Fourier 
transform: 
 ?̂?(𝑟) = ∫ 𝑑𝑘 ∙ 𝑆(?⃗⃗?)
𝑘𝑠
∙ 𝑒𝑖2𝜋(?⃗⃗?∙𝑟), [1-43] 
where the effective magnetization density is now a function of the position in image 
space and integrated over all of k-space. 
 
In order to sufficiently sample k-space prior image reconstruction, MRI uses data 
acquisition “recipes” called pulse sequences. These pulses sequences use a predetermined 
set of RF pulses, magnetic field gradient waveforms, and timing parameters. Thus, an 
MRI scanner is able to excite magnetization, apply the desired phase factors, and acquire 
data with the desired image contrast. The following sections describe examples of MRI 
pulse sequences that were used in this thesis, such as 2D gradient echo, 3D gradient echo, 




1.7.2 2D Gradient Echo Imaging 
A pulse sequence diagram for a typical 2D gradient echo image acquisition is shown in 
Figure 1-14. This pulse sequence can be broken down into four main steps, which are 
described separately below: RF pulse, slice-selection, phase encoding, and frequency 
encoding. Each time the pulse sequence shown in Figure 1-14 is played out, a single line 
of data in k-space is acquired. Therefore, the pulse sequence must be repeated many times 
in order to fully sample k-space, and the duration between each leading RF pulse is 
defined as the repetition time, TR. 
 
Figure 1-14: Pulse sequence diagram for a 2D gradient echo image acquisition. 
 
1.7.2.1 RF Pulse 
The pulse sequence begins with an RF pulse to tip the longitudinal magnetization into the 
transverse plane. In general, any desired flip angle may be used, and it need not be a 
constant. Thus, the flip angle and timing parameters are chosen carefully in order to 
achieve the desired image contrast and to use the available magnetization efficiently. In 
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conventional 1H MRI and inert fluorinated gas MRI, there is a trade-off between the 
between the signal gain from using high flip angles and the available longitudinal 
magnetization from T1 relaxation. Therefore, the optimal flip angle for a fixed TR and T1 
is given by the following equation: 
 𝜃 = cos−1 (𝑒
−
𝑇𝑅
𝑇1 ), [1-44] 
where 𝜃 is referred to as the Ernst angle, which ensures an optimal SNR efficiency. 
 
As noted in Section 1.6.5, the initially high longitudinal magnetization of HP gases is 
non-recoverable. Therefore low flip angles are typically used so that the available 
magnetization can be spread out over the entire data acquisition (123), such that the 
transverse magnetization following the nth RF pulse is given by the following equation: 
 𝑀𝑥𝑦(𝑛) = 𝑀(0) sin 𝜃 (cos 𝜃)
𝑛−1𝑒
(𝑛−1)∙𝑇𝑅
𝑇1 . [1-45] 
Eq. [1-45] is often referred to as a constant flip angle (CFA) approach. The disadvantage 
of using CFA is that the signal strength following each RF pulse will be non-uniform, 
which has a filtering effect on the final image (i.e. blurring). An alternative technique is 
to use variable flip angles (VFA), where each successive flip angle is incremented in 
order to yield a constant signal response as a function of RF pulse number (124).  
 
Each RF pulse has an associated bandwidth, 𝐵𝑊𝑅𝐹, or range of precessional frequencies 
that will be excited. Under the small flip angle approximation (typically less than 30°), 
the RF bandwidth can be determined by computing the Fourier transform of the RF pulse 
shape. For simplicity, a rectangular pulse is shown in Figure 1-14, which has a sinc-
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shaped profile in the frequency domain. In general, any arbitrary pulse shape may be 
used, depending on the desired timing parameters and frequency profile. 
 
1.7.2.2 Slice Selection 
In order to excite a 2D slice of magnetization, the RF pulse is turned on in the presence of 
a magnetic field gradient, which is commonly referred to as the slice-select gradient. For 
illustrative purposes, the slice select gradient is shown in Figure 1-14 in the z-direction. 
By convention, the z-direction is always in the direction of the magnet bore, and therefore 
the pulse sequence shown in Figure 1-14 will excite an axial slice of magnetization in the 
xy-plane. Imaging can also be performed in the axial, coronal or sagittal planes, and a 
linear combination of gradient magnetic fields can excite any arbitrary plane of 
magnetization (i.e. an oblique plane).  
 







where 𝐵𝑊𝑅𝐹 is the RF bandwidth, and 𝐺𝑧 is the strength of the magnetic field gradient. 
Since the transverse magnetization accumulates phase while the slice-select gradient is 
turned on, an additional gradient is applied in the opposite direction to rewind the 
accumulated phase back to zero. The second gradient lobe has half the area of the first 
lobe, since most of the magnetization is assumed to be tipped into the transverse plane at 





1.7.2.3 Phase Encoding 
Following slice selection, a phase encoding gradient is applied, and this gradient is 
typically shown in the y-direction for illustrative purposes. While the magnetic field 
gradient is turned on, the spins precess at a frequency that is a known function of position 
(i.e. 𝜔(𝑦) = 𝛾𝐺𝑦𝑦). When the gradient is turned off, the spins return to their original 
precessional frequency, but they retain the phase that was accumulated while the 
magnetic field gradient was turned on. Therefore, the position in k-space after the phase 




𝑇𝑃𝐸 ∙ 𝐺𝑦, [1-47] 
where 𝑇𝑃𝐸 is the duration of the phase encoding gradient. For simplicity, Eq. [1-47] 
assumes the integral from Eq. [1-40] was performed over a rectangular gradient 
waveform, while most gradients actually use a trapezoidal profile.  
 
2D gradient echo imaging samples k-space in a Cartesian fashion, and each repetition of 
the pulse sequence acquires one line in k-space. Thus, for each line of k-space that is to 
be acquired, a phase encoding gradient with a slightly different maximum amplitude must 
be turned on. In other words, each repetition of the pulse sequence moves the acquisition 
to a different 𝑘𝑦 position in k-space. For this reason, multiple overlapping Gy lobes are 
shown in Figure 1-14. The field of view (FOV) and resolution in the y-direction, ∆𝑦, are 
related to k-space through the following expressions: 







2𝜋) ∆𝐺𝑦 ∙ 𝑇𝑃𝐸
,         𝑘𝑦,𝑚𝑎𝑥 =
1
2∆𝑦
 , [1-48] 
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where ∆𝑘𝑦 is the sampling period in the 𝑘𝑦 direction, 𝑘𝑦,𝑚𝑎𝑥 is the full extent of k-space 
coverage in the positive y-direction, and ∆𝐺𝑦 is the difference in the maximum 𝐺𝑦 
gradient amplitudes for two consecutive lines of k-space. 
 
1.7.2.4 Frequency Encoding and Readout 
Following phase encoding, frequency encoding gradients are applied and data acquisition 
(ACQ) occurs. In Figure 1-14, the frequency encoding gradient is shown in the x-
direction. A pre-phasing gradient of negative amplitude is applied first, in order to add 
phase in the negative kx-direction. Then a readout gradient with positive amplitude 
applies phase in the positive kx-direction, during which data is acquired. The gradient 
echo is defined as the point during the readout where kx = 0, and the time between the RF 
pulse and the centre of the gradient echo is called the echo time, TE. If the readout 
gradient has twice the area of the pre-phasing gradient, then gradient echo occurs at 
exactly the centre of the readout gradient. 
 
Figure 1-15 shows examples of k-space trajectories for a gradient echo acquisition. 
Following the RF pulse and slice select gradient, the transverse magnetization has an 
initial phase of kxy = 0. If the pre-phasing gradient is turned on at the same time as the 
phase-encoding gradient, then the trajectory will move diagonally away from the centre 
of k-space. When the readout gradient is turned on, the trajectory moves horizontally to 
the right, and a line of k-space data is collected. Therefore, by repeating the pulse 
sequence with a slightly different phase encoding gradient, k-space can be uniformly 




Figure 1-15: Three k-space trajectories in a gradient echo pulse sequence. 
 
In order to reduce the TE and overall scan duration, k-space can be intentionally under-
sampled. In such cases, the conjugate symmetry of k-space can be used to reconstruct the 
correct image. For example, k-space could be under-sampled by only collecting only a 
fraction of the horizontal lines shown in Figure 1-15. This is achievable by reducing the 
duration of the pre-phasing gradient, and the fraction of the horizontal line that is actually 
collected is referred to as the partial echo factor.  
 
Similar to Eq. [1-48], the FOV and resolution in the x-direction, ∆𝑥, are related to k-space 
through the following expressions: 







2𝜋) 𝐺𝑥 ∙ 𝜏𝑠
,         𝑘𝑥,𝑚𝑎𝑥 =
1
2∆𝑥
 , [1-49] 
where 𝐺𝑥 is the strength of the readout gradient, and 𝜏𝑠 is the time required to sample 
each data point. The readout bandwidth is simply the inverse of the sampling time:  
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Thus, k-space is adequately sampled when the following Nyquist condition is met (119): 
 𝑛𝑘𝑥𝑛𝑘𝑦 ≥ 4(𝑘𝑚𝑎𝑥 ∙ 𝐹𝑂𝑉)
2, [1-51] 
where 𝑛𝑘𝑥 and 𝑛𝑘𝑦 are the number sampled k-space points in the kx- and ky-directions, 
respectively. 
 
1.7.3 3D Gradient Echo Imaging 
With a few modifications, the 2D gradient echo image acquisition described in Section 
1.7.2 can be extended to 3D imaging. Figure 1-16 shows a pulse sequence diagram for a 
typical 3D gradient echo image acquisition. 3D acquisitions generally use “hard” RF 
pulses, which have a short duration and broad excitation profile in the frequency domain. 
The magnitude of the slice selection gradient can be reduced in order to excite a thick 
slab of magnetization, or slice selection can be omitted completely. In Figure 1-16, phase 
encoding gradients are applied simultaneously in two directions, Gy and Gz, followed by 
frequency encoding gradients along Gx. The k-space trajectory for a 3D gradient echo is 
very similar to the 2D case shown in Figure 1-15, except the Gz phase encoding gradients 




Figure 1-16: Pulse sequence diagram for a 3D gradient echo image acquisition. 
 
It should be noted that since more phase encoding steps are needed to acquire a 3D 
image, the acquisition time will be significantly increased compared to 2D imaging. Once 
a 3D k-space dataset has been sufficiently sampled, a 3D inverse Fourier transform can 
be used to reconstruct the final 3D image. 
 
1.7.4 UTE Imaging 
The primary purpose of UTE is to enable imaging of signal sources that have very short 
T2
* relaxation times (125). Figure 1-17 shows a pulse sequence diagram of the 3D UTE 
acquisition used in this thesis. Similar to 3D imaging, UTE uses a hard RF pulse. Instead 
of using slice or slab selection, a brief phase encoding gradient is played out along Gz. 
Readout gradients are then played out in both the Gx and Gy directions. Unlike gradient 
echo imaging, where data acquisition only occurs during the gradient waveform plateau, 




Figure 1-17: Pulse sequence diagram for a 3D ultrashort echo time (UTE) acquisition. 
 
Since the Gx and Gy gradients shown in Figure 1-17 are of equal magnitude, the resulting 
k-space trajectory will be a radial spoke that starts at the centre of k-space and is 45° from 
both the kx- and ky-axes. For each repetition of the pulse sequence, a different linear 
combination of Gx and Gy gradients is used to acquire many different radial spokes to fill 
up k-space. A few examples of these radial k-space trajectories are shown in Figure 1-18. 
Since UTE uses a polar coordinate system rather than Cartesian sampling, k-space data 
points are closer together near the center of k-space and further apart near the edge of k-
space. As a result, more radial spokes need to be acquired in order to adequately sample 
k-space. That is, radial k-space trajectories have the following Nyquist condition (119): 
 𝑛𝑘𝑟𝑛𝑘𝜃 ≥ 2𝜋(𝑘𝑚𝑎𝑥 ∙ 𝐹𝑂𝑉)
2, [1-52] 
where 𝑛𝑘𝑟 and 𝑛𝑘𝜃 are the number sampled k-space points in the radial and polar 
directions, respectively. Therefore, fully sampled UTE acquisitions will likely be longer 




Figure 1-18: Examples of radial k-space trajectories in a UTE image acquisition. 
 
With additional phase encoding in the kz-direction, the final 3D k-space dataset will look 
like a “stack of stars”. The k-space data is then gridded onto a Cartesian plane using 
interpolation techniques, and a 3D inverse Fourier transform is used to reconstruct the 3D 
final image. 
 
It should also be noted that other variants of UTE appear in the literature, such as ZTE 
(60), and PETRA (62). Most notably, UTE imaging in the literature generally uses a 3D 
isotropic approach, where the image resolution is exactly the same in each of the x-, y-, 
and z-directions (59). This is accomplished by omitting the phase encoding gradient in 
the z-direction and replacing it with a readout gradient. This modification can 
substantially reduce the TE, and with many linear combinations of readout gradients in 
the x-, y-, and z-directions, the resulting k-space trajectories resemble a koosh ball. 





3D inverse Fourier transform. Based on the timing and geometric parameters that were 
desired, the stack of stars UTE approach was the primary technique used for 19F human 
lung imaging in this thesis. 
 
1.7.5 X-Centric Imaging 
X-centric imaging is a Cartesian technique that ensures a short TE and short acquisition 
window, which is especially important for imaging short T2
* signal sources. The x-centric 
pulse sequence is essentially a variant of 2D gradient echo imaging with a partial echo 
factor of 50.5% (123,126). Figure 1-19 shows an example of an x-centric pulse sequence 
diagram. In this case, the RF pulse, slice select gradient, and phase encoding gradient are 
the same as for 2D gradient echo imaging; however, the pre-phasing gradient along the x-
direction is very small. Thus, the TE will be very short, since k-space trajectories take 
less time to pass through kx = 0.  
 











Each repetition of the x-centric pulse sequence will acquire half of a horizontal line in k-
space, plus a few additional points prior to kx = 0. Some examples of x-centric k-space 
trajectories are shown in Figure 1-20. The gradients shown in Figure 1-19 will produce k-
space trajectories that acquire data in the positive x-direction. In order to acquire a 
complete horizontal line in k-space, the pulse sequence is repeated with the opposite 
readout gradient polarity. The extra points prior to kx = 0 allow for phase correction prior 
to joining the two halves of k-space. Similar to 2D gradient echo imaging, a simple 2D 
inverse Fourier transform of the phase-corrected and joined k-space data yields the final 
image. Unlike UTE imaging, gridding and interpolation is not required for image 
reconstruction. 
 
Figure 1-20: k-space trajectories for a 2D x-centric pulse sequence. Since x-centric uses a partial echo 
factor of 50.5%, the sequence is repeated with the opposite readout gradient polarity. In order to preserve 






1.7.6 SNR Considerations 
The signal-to-noise ratio (SNR) is a very simple indicator of image quality, and it is 
generally defined as the mean signal value divided by the standard deviation of the noise. 
As discussed in Section 1.6, the received signal is dependent on factors such as the 
available magnetization, flip angle, T1, T2, and T2
*. In addition, the choice of pulse 
sequence and timing parameters have a substantial impact on SNR. For example, if the 
TR is used to control the amount T1 recovery and the TE is used to control the amount of 
T2
* decay, the SNR is as follows: 









The above relationship essentially determines the image contrast, which might be T1- 
and/or T2
*-weighted given a particular TR and TE. In addition, the SNR is also dependent 
on the voxel size and acquisition time in the following way: 
 
𝑆𝑁𝑅 ∝ (𝑣𝑜𝑥𝑒𝑙 𝑠𝑖𝑧𝑒) ∙ √𝑟𝑒𝑎𝑑𝑜𝑢𝑡 𝑡𝑖𝑚𝑒 





where ∆𝑥, ∆𝑦, and ∆𝑧 are the physical dimensions of the voxel (i.e. resolution); 𝑁𝑎𝑣𝑔 is 
the number of signal averages; 𝑁𝑥 is the number of readout points in the x-direction; 𝑁𝑦 
and 𝑁𝑧 are the number of phase encodes in the 𝑦- and 𝑧- directions, respectively; and 𝐵𝑊 
is the readout bandwidth (i.e. the inverse of the sampling time). 
 
A major focus of this thesis involves comparing the SNR and image quality from various 
acquisition strategies, such as UTE and gradient echo, as well as comparing the image 
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quality from various signal sources, including inert fluorinated gases and HP gases. 
Given the preceding discussion regarding MRI data acquisition, there are many factors 
that contribute to image SNR. One approach to comparing the image quality from 
different acquisitions would be to calculate the SNR efficiency, which corrects for 
differences in relaxation effects and pulse sequence parameters. Although SNR efficiency 
can potentially provide a robust and quantitative comparison, this thesis focused more on 
the pragmatic aspects of lung imaging and its potential applications. In practice, lung 
imaging is typically constrained by the length of time that a subject is able to hold their 
breath, and this factor puts an upper limit on how much k-space sampling can occur 
within a breath-hold (i.e. the readout time in the above SNR equation). Therefore, instead 
of presenting comparisons of SNR efficiencies, the comparisons presented in this thesis 
represent the highest possible SNR that can be achieved within a breath-hold for a given 
set of conditions. 
 
1.8 Comparison of 129Xe, 3He, and Inert Fluorinated Gases 
After discussing basic NMR and MRI principles, these concepts can now be used to 
understand how the differences in the physical properties of the inhaled gases relate to the 
imaging parameters and acquisition techniques that are needed for pulmonary imaging. 
129Xe, 3He, PFP, and SF6 are all non-toxic gases that can safely be used in MR imaging of 
lungs; however, they have vastly different properties that must be taken into account in 
order to design an imaging protocol that yields the highest possible signal quality. A 
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comparison of the physical properties of 129Xe, 3He, PFP, and SF6 is shown below in 
Table 1-2. 
 
Table 1-2: A comparison of the physical properties of 129Xe, 3He and inert fluorinated gases (100,116,127). 
Parameter 129Xe 3He 19F (PFP) 19F (SF6) 
Nuclear Spin, I 1/2 1/2 1/2 
Gyromagnetic ratio, γ, [MHz·rad·T-1] -74.519 -203.814 251.818 
Natural Abundance [%] 26.4 1.37 × 10-4 100 
Chemical shift range, Δδ [ppm] 250 0.8 150* 
Spin-lattice relaxation time in the lungs, 
T1 
20 s 25 s 12.4 ms† 1.2 ms†  
Self-diffusion coefficient, D0, [cm2·s-1] 0.061 2.05 0.023 0.033 
Diffusion coefficient in air, D, [cm2·s-1] 0.14 0.86 0.071 0.094 
Ostwald solubility, L 0.17 0.0085 5.2 × 10-4 5.4 × 10-3 
Density, [g·L-1] 5.75 0.134 8.17 6.51 
*Approximate chemical shift between PFP and SF6 resonances. PFP also has two peaks which are 
separated by ~48 ppm. 
†The reported T1 values of PFP and SF6 assume the gas is mixed with ~20% O2. 
 
129Xe, 3He, and 19F are all NMR sensitive nuclei, as they have a nuclear spin of ½. 3He 
and 19F have high gyromagnetic ratios compared to 129Xe, which leads to a greater signal 
strength. At thermal equilibrium, Eq. [1-38] demonstrates that the received signal is 
proportional to γ3, with one factor of γ coming from the precessional frequency and two 
factors incorporated into the magnetization density (i.e. one from the magnetic moment 
and one from thermal polarization). For HP gases, the polarization depends on external 
non-equilibrium factors, and therefore, the received signal scales according to γ2.  
 
3He, PFP, and SF6 all have a negligible solubility (88,128), whereas 
129Xe is able to 
dissolve into blood and tissue. Due to the large chemical shift range of 129Xe, unique 
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spectral peaks can be detected that correspond to the lung airspaces, barrier tissues, and 
red blood cells (RBCs). Therefore, HP 129Xe allows for the measurement of perfusion and 
gas exchange in the lungs (129-133), as well as sensory stimulation in the brain 
(134,135). It should also be noted that Xe has anaesthetic properties in high 
concentrations (136), and therefore safety considerations must be taken into account 
when developing human breathing protocols (137). Fluorinated gases are non-toxic and 
safe for human inhalation, as they are commonly used in pulmonary function tests, such 
SF6 (albeit in small concentrations) in the multiple inert gas elimination technique 
(MIGET) (138). Inert fluorinated gases have other medical imaging applications, such as 
fluorinated microbubbles that are used as contrast agents in ultrasound (139). Preliminary 
imaging results have shown that the inhalation of highly concentrated fluorinated gas 
mixtures has been well tolerated (115,116); however, future work will continue to 
evaluate safety and tolerability on an ongoing basis. In addition, PFP and SF6 are very 
heavy gases compared to 3He, and the density of 129Xe is slightly less than the density of 
SF6. Future studies will need to determine whether the high density of inert fluorinated 
gases adversely affects the resulting images and the functional biomarkers that are 
derived from those images. 
 
The T1 relaxation times of PFP and SF6 in the lungs are substantially shorter than HP 
gases (115,140-142). In HP gas MRI, T1 characterizes the decay of the HP magnetization 
back to thermal equilibrium, and therefore a long T1 (i.e. on the order of tens of seconds) 
is beneficial for imaging within a single breath-hold. In the context of inert fluorinated 
gas MRI, a short T1 is advantageous, since averaging is necessary to overcome a thermal 
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polarization that has much less available magnetization than HP gases. Therefore, it is 
possible to use a short TR (i.e. a few ms for SF6 and a few tens of ms for PFP) and many 
averages to acquire inert fluorinated gas MR lung images within a single breath-hold.  
 
There are several different fluorinated gases that can potentially be used in 19F MRI, 
including PFP, SF6, CF4, and C2F6. However, the choice of gas for a particular 
experiment depends on a number of factors, including the number of 19F nuclei per 
molecule, differences in relaxation properties, availability, and the need for medical grade 
mixtures. The human inert fluorinated gas MR imaging presented in this thesis used PFP 
as the inhaled signal source, while SF6 was used in the animal work presented in this 
thesis. Both PFP and SF6 have six magnetically equivalent 
19F nuclei; however, PFP has 
two additional 19F nuclei that contribute to a smaller signal peak that is separated from 
the main peak by about 48 ppm. The RF excitation bandwidth used in this thesis was less 
than the chemical shift between the two PFP peaks, and therefore, no substantial 
chemical shift artifacts are visible in PFP images.  
 
PFP was primarily used in human imaging due to its ideal T1 relaxation time. PFP has a 
T1 of about 12 ms in human lungs, and at a TR of 20 ms, the Ernst angle of 79° would 
yield the highest possible SNR efficiency. In this thesis, a flip angle of 70° was used for 
human lung imaging due to RF power limitations. The RF coil used in this thesis had a 
minimal reflected power (-16 dB or ~2.5%), whereas the transmitting path from the 4 kW 
RF amplifier suffered from 3 dB losses that resulted in an available RF power of 
approximately 2 kW at the coil. Since SF6 has a much shorter T1, using similar Ernst 
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angle conditions would require either a shorter TR or a higher flip angle (compared to the 
PFP settings). Therefore, PFP was ideal for human imaging because it would not have 
been possible to image SF6 under Ernst angle conditions, given the limits on the available 
RF power. However, SF6 was ideal for animal imaging, since small animal RF coils 
require less power. SF6 imaging in animal lungs is possible under near-Ernst angle 
conditions with a TR of 4 ms and a flip angle of 70°. Therefore, the shorter T1 of SF6 is 
advantageous, because more averaging is possible with SF6 compared to PFP during the 
same breath-hold duration. 
 
Since O2 is paramagnetic, it strongly affects the T1 of 
129Xe and 3He. Under ideal 
conditions (i.e. a perfectly homogeneous external magnetic field), the T1 of HP 
129Xe and 
3He can be on the order of several hours (88), whereas the T1 is reduced to a few tens of 
seconds inside the lungs and in the presence of O2. In fact, the T1 of 
129Xe and 3He is 
proportional to the concentration of O2, and this relationship can be exploited to map the 
alveolar partial pressure of oxygen (pAO2) (108). On the other hand, the T1 relaxation of 
inert fluorinated gases is dominated by spin rotation interactions (i.e. the coupling of 
nuclear spins to local magnetic fields produced by the rotation of large molecules) (143), 
and the T1 is generally on the order of a few milliseconds. Since the presence of O2 has a 
much less dramatic effect on the T1 of fluorinated gases than it does for HP gases, 
fluorinated gases can be mixed with O2 to improve patient safety with little impact on 




The presence of O2 in inert fluorinated gas mixtures can potentially allow for longer 
scans than anoxic HP gas inhalations. Whereas HP gas inhalations have historically used 
a bolus inhalation on the order of 1 L and a 10 – 15 s breath-hold, a mixture of inert 
fluorinated gases and O2 can be breathed continuously. After several breaths of the gas 
mixture, the concentration of inert fluorinated gases will reach a steady state in the lungs, 
thereby maximizing the available magnetization for imaging. Continuous breathing of 
inert fluorinated gases also allows for dynamic imaging measurements, such as wash-in 
and wash-out time constants, and it can potentially allow for the acquisition of more 
physiologically meaningful information (144-146). Likewise, multiple breath HP gas 
imaging techniques are now being explored for the measurement physiologically 
meaningful biomarkers; however, these techniques require additional considerations to 
account for potential signal losses due to O2 and T1 (147,148). 
 
In terms of cost, 3He is an exceedingly rare and expensive isotope, and its only means of 
production is through the radioactive decay of tritium (88). The high costs of 3He are also 
partly due to the US government sequestering 3He for use in neutron detectors for 
national security (149,150). For this reason, investigators are now turning their attention 
towards HP 129Xe imaging, since the source gas is cheaper and more widely available. 
129Xe arguably has a better chance than 3He of being clinically adopted as a routine 
pulmonary imaging modality; however, the majority of the 129Xe literature uses gas 
mixtures that have been isotopically enriched with up to 90% 129Xe (compared to 
naturally abundant Xe gas that contains 26% 129Xe). Therefore, HP 129Xe can also be very 
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expensive, and investigators are now exploring the feasibility of imaging using naturally 
abundant Xe gas mixtures (80,151).  
 
SEOP-based polarizers are now commercially available for the production of HP 3He and 
129Xe for clinical studies (Polarean, Inc. and Xemed LLC). Improvements in polarizer 
technology are ongoing (152), including the development of an “open source” 3D-printed 
design (153,154); however it should be noted that polarizers require a substantial capital 
investment, as well as ongoing maintenance costs and specialized personnel. Conversely, 
inert fluorinated gases do not need to be hyperpolarized prior to their use in MRI, which 
obviates the need for expensive polarizer technology. Furthermore, inert fluorinated gases 
are relatively abundant and inexpensive compared to HP gases, as they have numerous 
industrial applications, such as in semiconductor processing and electrical insulation 
(155). It should also be noted that fluorinated gases are potent greenhouse gases (156), 
and therefore, minimizing the environmental impact will be an important consideration. 
Fortunately, fluorinated gases do not deplete atmospheric ozone (113); however, future 
developments will continue to investigate gas delivery systems that have the ability to 
capture and recycle the exhaled gases (117). 
 
1.9 Thesis Outline 
Chapter 1 has described the motivation for studying respiratory diseases, basic lung 
physiology and PFTs. An overview of lung imaging using various functional imaging 
modalities was presented, including CT, nuclear medicine, conventional 1H MRI, HP gas 
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MRI, and inert fluorinated gas MRI. The basic principles of NMR and MRI physics were 
presented, followed by a comparison of the physical properties of the inhaled gases used 
in this thesis: 129Xe, 3He, PFP, and SF6. 
 
Chapters 2 through 5 are briefly described below; these chapters represent work that was 
completed in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy in Biotechnology at Lakehead University. Chapter 2 describes the first inert 
fluorinated gas MR imaging study that was performed in Thunder Bay, Ontario. In this 
work, 19F 3D MR imaging was performed in a group of healthy volunteers using an 
optimized UTE technique, and images from different gas breathing techniques were 
quantitatively compared. This work was published in the peer-reviewed journal, 
Radiology, in 2013. 
 
Since inert fluorinated gas MRI is a technique that is still under development, 
comparisons between various acquisition techniques are required in order to fully 
optimize the image quality. Chapter 3 describes a quantitative comparison of inert 
fluorinated gas MR imaging performed using both UTE and gradient echo imaging. In 
this work, 19F MR imaging was performed in both healthy volunteers and in a resolution 
phantom. This work is currently in preparation for submission to a peer-reviewed journal 
as an original research article. 
 
Chapter 4 discusses initial efforts to quantify imaging biomarkers using inert fluorinated 
gas MRI. This chapter presents a preliminary comparison of inert fluorinated gas MRI 
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and HP 3He MRI, along with preliminary measurements of 19F ADC and gravitational 
gradients of ventilation in healthy volunteers. Portions of Chapter 4 were published in the 
peer-reviewed journal, NMR in Biomedicine, as a review article in 2014. 
 
In order to demonstrate the potential for using image-derived biomarkers to provide 
quantitative functional information, Chapter 5 presents an inert fluorinated gas MRI 
ventilation mapping study that was performed in rat models of pulmonary inflammation 
and fibrosis. Fractional ventilation was compared between disease model rats and healthy 
controls, and the presence of inflammation was confirmed by histology. This work is 
currently in preparation for submission to a peer-reviewed journal as an original research 
article. 
 
Chapter 6 provides a brief summary of this work and discusses possible future directions. 
Overall, this work may help to demonstrate that inert fluorinated gas MRI has the 
potential to become a routine clinical imaging modality that can provide diagnostic 
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2 Pulmonary Ultrashort Echo Time 19F MR Imaging with Inhaled Fluorinated 
Gas Mixtures in Healthy Volunteers: Feasibility 
Pulmonary Ultrashort Echo Time 19F MR Imaging 




Purpose: The purpose of this study was to perform static breath-hold fluorine-19 (19F) 
3D ultra-short echo time (UTE) magnetic resonance imaging (MRI) of the lungs in 
healthy volunteers using a mixture 79% perfluoropropane (PFP) and 21% O2. 
 
Methods: This study protocol was approved by the local research ethics board and by 
Health Canada. All subjects provided written informed consent prior to their participation 
in this study. Ten healthy volunteers underwent MR imaging at 3.0 T. 19F 3D UTE 
images were acquired during a 15 second breath-hold, following one of two breathing 
protocols: (A) a 1 L inhalation of a mixture of 79% perfluoropropane (PFP) and 21% O2, 
or (B) continuous breathing from a 5 L bag of a mixture of 79% PFP and 21% O2, 
followed by a 1 L inhalation of the same PFP/O2 mixture from a separate bag, and 
subsequent breath-hold. The signal-to-noise ratio (SNR) was measured in the three most 
central image slices, and compared between breathing protocols using an unpaired t-test. 
                                                 
*
 This chapter was originally published in Radiology, 2013; 269: 903–909, DOI:10.1148/radiol.13130609, 
and was co-authored by Marcus J. Couch, Iain K. Ball, Tao Li, Matthew S. Fox, Shalyn L. Littlefield, 
Birubi Biman, and Mitchell S. Albert. 
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Results: Overall, the SNR was significantly greater for breathing protocol B (continuous 
breathing) compared to breathing protocol A (single breath) (p = 0.018). The mean SNR 
(±standard deviation) was 18 ± 6 and 32 ± 6, for images acquired using breathing 
protocols A and B, respectively. Breathing protocol B improves SNR by washing out the 
air from the lungs and increasing the PFP concentration prior to 19F imaging.  
 
Conclusion: This feasibility study demonstrates the use of 19F 3D UTE static breath-hold 
imaging of human lungs with inert fluorinated gases. 
 
2.2 Introduction 
Chronic respiratory diseases, such as asthma, chronic obstructive pulmonary disease 
(COPD) and cystic fibrosis are a significant global health care burden. COPD is currently 
the fourth leading cause of death in the United States (1), and there is a need in the 
medical community for functional imaging techniques that can provide regional data on 
lung function. Available modalities for the assessment of lung function include 
spirometry, nuclear medicine imaging using radio-isotopes, chest X-ray, computed 
tomography (CT) and conventional proton (1H) magnetic resonance imaging (MRI) (2,3). 
Spirometry has the advantage of being low cost and widely available but provides only 
information on global lung function. Chest X-rays, nuclear medicine and CT all expose 




1H MRI cannot typically provide high quality images of the lungs due to the low tissue 
density, high magnetic susceptibility differences at air/tissue interfaces and respiratory 
motion. The image quality from 1H MRI can be improved through the use of ultra-short 
echo time (UTE) pulse sequences, however, this technique can only obtain structural 
information (4). It is possible to obtain some functional information from the lungs using 
O2 enhanced 
1H MRI (5), however, it is unclear whether the O2 enhancement represents 
ventilation of the air spaces, since the signal change arises from protons interacting with 
O2 dissolved in tissue (3). Hyperpolarized (HP) noble gas MRI, using helium-3 (
3He) and 
xenon-129 (129Xe), is a non-invasive imaging technique that allows for the direct 
measurement of lung ventilation, gas exchange, and lung microstructure (6,7). 
Unfortunately, 3He is an extremely scarce and expensive isotope. Although 129Xe is more 
plentiful and less expensive, both 3He and 129Xe require a polarizer to prepare and 
process the gases.  
 
An attractive alternative to HP noble gas MRI is functional MRI using inert fluorinated 
gases, such as sulfur hexafluoride (SF6), hexafluoroethane (C2F6), and perfluoropropane 
(C3F8 or PFP) as inhaled signal sources for MRI. These gases offer the advantages of 
being nontoxic, abundant, and inexpensive compared to HP noble gases. Furthermore, 
inert fluorinated gases, due to the high gyromagnetic ratio of fluorine-19 (19F) and short 
longitudinal relaxation times, do not need to be hyperpolarized prior to their use in MRI. 
This eliminates the need for an expensive polarizer. 3D inert fluorinated gas MRI was 
initially reported over 15 years ago, where it was used to acquire 3D images of rat lungs 
during continuous breathing of a mixture of C2F6 and O2 (8). Investigators quickly saw 
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the potential for this technique to provide functional measurements in animal lungs, 
including wash-in/wash-out kinetics of pulmonary ventilation (9), volume measurements 
throughout the respiratory cycle (10), and the measurement of ventilation/perfusion ratios 
(11,12). Sub-second imaging has been demonstrated with SF6 in pigs, which allows for 
fast and dynamic measurements of gas kinetics (13). Wash-in/wash-out kinetics of 
pulmonary ventilation agree well with respiratory gas analysis (14). Efforts have been 
made to perform diffusion-weighted imaging in rat lungs using inert fluorinated gas MRI 
(15,16), including a study of elastase-induced emphysema in rats (17). Diffusion 
measurements have also been performed in healthy and emphysematous excised human 
lungs (18,19).  
 
Recently, Soher et al. demonstrated lung imaging using inert fluorinated gases in a single 
healthy human subject (20). 3D gradient echo imaging was performed following 
inhalation of PFP through a gas-delivery system. Although this was a promising 
development, the image quality was less than what can currently be achieved using HP 
noble gas MRI. There is a clear need to further develop and improve the image quality of 
MRI using inert fluorinated gases. Since inert fluorinated gases are known to have short 
T2
* relaxation times (12), 3D UTE is expected to have a higher signal-to-noise ratio 
(SNR) than 3D gradient echo imaging. The purpose of this study was to perform static 
breath-hold 19F 3D UTE MRI of the lungs in healthy volunteers using a mixture 79% PFP 







This study protocol was approved by the local research ethics board and by Health 
Canada. All subjects provided written informed consent prior to their participation in this 
study. Ten healthy volunteers (8 female, 2 male) were enrolled with no history of chronic 
respiratory disease, and a smoking history of less than 10 pack-years. A pack-year was 
defined as the number of cigarette packs smoked per day multiplied by the number of 
years the individual smoked. The mean age of all subjects (±standard deviation) was 28 ± 
11 years. Men had a mean age of 38.5 with a range of 20 to 57. Women had a mean age 
of 25.3 with a range of 21 to 29. Digital pulse oximetry was used to measure peripheral 
oxygen saturation (SpO2) for all subjects during scanning sessions (Veris, Medrad, 
Warrendale, PA).  
 
2.3.2 Image Acquisition 
Imaging was performed using a 3.0 T Philips Achieva scanner and a flexible wrap-around 
quadrature transmit/receive coil (Clinical MR Solutions, Brookfield, WI) tuned to the 19F 
resonance frequency (120.15 MHz at 3.0 T). Since the resonance frequencies of 19F and 
1H are relatively close, the 19F coil was actively proton blocked to allow for artifact-free 
1H imaging while the subject was lying inside the 19F coil. Active decoupling was 
achieved by using PIN diodes that are controlled with an external DC power supply. The 
PIN diodes are able to selectively control which components of the coil are turned on in 
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order to shift the resonance frequency of the coil away from the 19F frequency during 1H 
scanning (21,22). Conventional 1H MRI was performed prior to 19F MRI with subjects 
imaged during a 1 L breath-hold of air. 1H images were acquired using a 2D multi-slice 
gradient echo acquisition, and were used as reference scans for planning 3D 19F images.  
 
Prior to 19F imaging, the flip angle was calibrated for each participant. Due to differences 
in subject size (and hence different coil loading conditions), the RF power required to 
produce a given flip angle may vary slightly. To calibrate the flip angle, subjects inhaled 
a 1 L Tedlar bag (Jensen Inert Products, Coral Springs, FL) of a mixture of 79% PFP and 
21% O2 (Air Liquide, Plumsteadville, PA) and held their breath for 15 seconds. During 
this breath-hold, a series of whole-lung spectroscopic acquisitions were performed with 
increasing RF power (23). 20 FIDs were collected with the following settings: TR = 750 
ms, TE = 0.83 ms, 2048 points, bandwidth = 8 kHz, starting flip angle = 10º, and flip 
angle spacing = 10º. Figure 2-1 shows an ideal 19F flip angle calibration acquired in a 
fluorinated gas-filled phantom. As expected, the 90º RF pulse yields the maximum signal 
intensity, while the 180º RF pulse yields the minimum signal intensity. If the flip angle 
was overpowered, the curve in Figure 2-1 would shift to the left; conversely, the 
calibration curve would shift to the right if the flip angle was underpowered. Using this 
spectroscopic approach, the transmitter gain can be adjusted such that the maximum 




Figure 2-1: Ideal flip angle sweep consisting of 20 spectra with increasing flip angles. 19F spectra were 
acquired in a fluorinated gas-filled phantom. As expected, a 90º RF pulse yields the highest possible signal 
intensity. 
 
Following calibration, 19F lung images were acquired following one of two breathing 
protocols: (A) a 1 L inhalation of a mixture of 79% PFP and 21% O2 from a single Tedlar 
bag followed by a 15 s breath-hold, or (B) continuous breathing from a 5 L Tedlar bag of 
a mixture of 79% PFP and 21% O2, followed by a 1 L inhalation of the same PFP/O2 
mixture from a separate Tedlar bag, and a 15 s breath-hold. Subjects were instructed to 
inhale a normal tidal volume of gas from the 5 L bag, and exhale around the tube, and to 
continue this procedure until the bag was empty. The second Tedlar bag filled with 1 L of 
gas allowed the subsequent image to be acquired at a reproducible lung inflation state. 
 
19F 3D UTE images were acquired with the following settings: TR = 20 ms, TE = 0.2 ms, 
matrix = 64 x 64, in-plane FOV = 450 x 450 mm2, flip angle = 70°, non-selective 






























acquired at 750 different angles starting from the center of k-space. Due to scanner and 
hardware limitations, 0.2 ms was the shortest possible TE. The T1 of PFP was measured 
to be 12.4 ms in the lungs at 3.0 T, which is close to previously reported in vitro T1 values 
(24). Therefore, a flip angle of 70° was close to the Ernst angle (78.5°) for a TR of 20 ms. 
For breathing protocol A, 8 slices were reconstructed in the coronal or axial plane with a 
thickness of 22 mm, while in breathing protocol B, 12 slices were reconstructed in the 
coronal or axial plane with a thickness of 15 mm. The signal-to-noise ratio (SNR) was 
measured by finding the mean signal value from a rectangular region of interest (ROI) in 
the right lung, and dividing by the standard deviation of noise from a similar ROI and in 
the background. The SNR values from the two breathing protocols were compared using 
an unpaired t-test in Graphpad Prism (GraphPad Software, La Jolla, CA), and p < 0.05 
was considered significant. 
 
2.4 Results 
Table 2-1 summarizes the subject demographics, oxygen saturation, and image SNR for 
all 19F UTE acquisitions. SNR was measured from coronal images, and the error 
represents the standard deviation of SNR measurements in 3 central slices. For breathing 
protocol A, the mean SNR (±standard deviation) was 18 ± 6, while for breathing protocol 
B, the mean SNR was 32 ± 6. Overall, the SNR was significantly different for breathing 
protocols A and B (p = 0.018 by an unpaired t-test).  
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Table 2-1: Subject demographics, oxygen saturation, and SNR (± standard deviation) from all available 
coronal 19F 3D UTE images. The breathing protocol used for each subject is indicated. 










1 f 26 A 18.90 99 96 22 ± 3 
2 m 20 A 18.62 99 94 18 ± 2 
3 f 29 A 19.03 99 98 11 ± 1 
4 f 27 A 21.45 99 93 21 ± 2 
5 f 21 A 19.63 99 95 27 ± 2 
6 f 23 A 18.16 99 96 11 ± 1 
7* f 29 - 19.47 99 98 24 ± 4 
8 f 24 B 28.43 99 93 38 ± 4 
9 m 57 B 23.13 99 97 32 ± 2 
10 f 23 B 23.61 99 96 26 ± 2 
*For this subject only, the 1 L inhalation of the PFP/O2 mixture was preceded by a 1 L washout from a 
separate Tedlar bag of the PFP/O2 mixture. 
 
Figure 2-2 shows eight slices from a 19F 3D UTE lung image in the coronal plane that 
was acquired in subject #4. This static breath-hold image effectively visualizes the 
distribution of the PFP gas inside the lungs of the subject. This image was acquired using 
breathing protocol A, where a 15 s breath-hold followed a single 1 L inhalation of the 
PFP/O2 mixture. The SNR in the centre slices was 21 ± 2. Figure 2-3 shows eight slices 
of a 19F 3D UTE lung image that was acquired in the axial plane from subject #5, also 






Figure 2-2: 19F 3D UTE lung images acquired in the coronal plane from subject #4 during a 15 s breath-
hold, following inhalation of a 1 L mixture of 79% PFP and 21% O2 from a Tedlar bag. Images were 




Figure 2-3: 19F 3D UTE lung images acquired in the axial plane from subject #5 during a 15 s breath-hold, 
following inhalation of a 1 L mixture of 79% PFP and 21% O2 from a Tedlar bag. Images were reproduced 





Figure 2-4 shows 12 slices from a 19F 3D UTE lung image in the coronal plane that was 
acquired during a 15 second breath-hold in subject #9 using breathing protocol B: 
continuous breathing from a 5 L Tedlar bag of the PFP/O2 mixture, followed by a 1 L 
inhalation of the PFP/O2 mixture from a separate Tedlar bag. There was sufficient signal 
in the lungs to increase the number of slices from 8 to 12, and decrease the slice thickness 
from 22 mm to 15 mm, while maintaining full lung coverage. The SNR in the centre 
slices of Figure 2-4 was 32 ± 2.  
 
 
Figure 2-4:  19F 3D UTE lung images acquired in the coronal plane from subject #9 during a 15 s breath-
hold, following continuous breathing from a 5 L mixture of 79% PFP and 21% O2 and a 1 L inhalation of 




Figure 2-5 shows 12 slices from a 19F 3D UTE lung image in the axial plane that was 
acquired during a 15 second breath-hold in subject #8. Breathing protocol B was also 
used in Figure 2-5, and yielded an SNR in the center slices of 44 ± 4. 
 
 
Figure 2-5: 19F 3D UTE lung images acquired in the axial plane from subject #8 during a 15 s breath-hold, 
following continuous breathing from a 5 L mixture of 79% PFP and 21% O2 and a 1 L inhalation of the 
same mixture. Images were reproduced with permission (25). 
 
2.5 Discussion 
This feasibility study demonstrates the potential of 19F 3D UTE for imaging of human 
lungs with inert fluorinated gases. The images obtained using the single breath protocol 
had a reasonable SNR, which serves as a baseline for comparison since a similar 
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breathing protocol is generally used for HP 3He or 129Xe MRI. These images show 
substantial blurring and lack of edge detail due to the fact that radial acquisitions 
oversample the center of k-space while sparsely sampling the edges, effects which are 
compounded by the short T2
* of PFP. The true potential of this technique can be realized 
in the use of continuous breathing protocols. Subjects typically breathed the entire 5 L 
bag of the PFP/O2 mixture in 5-7 breaths, which effectively washes out most of the air 
from the lungs. The entire continuous breathing protocol, including the 15 second breath-
hold, was performed in less than one minute. In all subjects, the measured SPO2 never fell 
below 88%, which would be considered an adverse event (26), and therefore inhalation of 
the PFP/O2 mixture was well-tolerated in healthy subjects.  
 
With continuous breathing, there is a greater density of 19F nuclei in the lungs to provide 
a signal, and the PFP gas is able to reach the periphery of the lungs. The greater available 
magnetization leads to a higher image quality, and allows for more slices to be acquired 
at smaller slice thicknesses. The SNR from the center slices of images obtained using the 
continuous breathing protocol was a factor of 2 greater than the SNR from similar slices 
reported by Soher et al. (20). A number of factors contribute to this difference, including 
the shorter echo time used in UTE compared to 3D gradient echo, the low bandwidth 
used in this study (140 Hz/pixel compared to 200 Hz/pixel used by Soher et al.), and the 
use of continuous breathing.  
 
We recognize that there are a few limitations regarding the imaging technique and 
breathing protocols. There is a slight ‘halo’ artifact that appears around the lungs, which 
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is a consequence of the UTE technique, and points to the need for optimization of the 
trajectory and gradient delays to compensate for eddy currents. In general, UTE yields a 
high SNR for species that are known to have a short T2
*, such as inert fluorinated gases. 
The T2
* of PFP in human lungs was 2.2 ms, as measured from a single FID following a 
90° pulse. SF6 may benefit even more from a UTE acquisition, since it is expected to 
have a shorter T2
* than PFP (12). Another potential limitation to this imaging technique is 
the ability of patients with lung diseases to perform the breathing protocols, and this 
needs further investigation. Since it is possible to mix inert fluorinated gases with O2, this 
technique has an advantage over HP noble gases. Therefore, it is possible to maintain an 
acceptable PAO2 without a significant loss of image quality. 
  
2.6 Conclusion 
In this initial proof of concept study, static breath-hold imaging of inert fluorinated gases 
was performed in healthy subjects only. It may be possible to improve the image SNR 
through the use of respiratory-gated imaging as opposed to static breath-hold imaging. It 
will be of great interest to measure additional functional biomarkers, such as wash-
in/wash-out kinetics and the apparent diffusion coefficient (ADC), both of which have 
already been demonstrated in animals (9,16). 19F 3D UTE imaging may also be a useful 
tool for imaging the lungs of patients with chronic respiratory diseases, such as asthma, 
COPD, and cystic fibrosis. Overall, this feasibility study demonstrates the potential of 19F 
3D UTE MR imaging for visualizing the distribution of inert fluorinated gases in human 
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Optimized Strategies for Pulmonary 19F MRI Using 
Inert Fluorinated Gases and Comparison of 
Ultrashort Echo Time and Gradient Echo Imaging 
 
3.1 Abstract 
Purpose: Pulmonary fluorine-19 (19F) magnetic resonance imaging (MRI) using inert 
fluorinated gases is a technique that can potentially provide high quality images of lung 
structure and function; however, optimization studies are required in order to achieve the 
highest possible image quality with this relatively new technique. In this study, 19F 3D 
MRI of inert fluorinated gases was performed in both a resolution phantom and in the 
lungs of healthy volunteers. 19F lung images obtained in the same imaging session using 
ultrashort echo time (UTE) and gradient echo techniques were quantitatively compared.  
 
Methods: Five healthy volunteers were imaged at 3.0 T following continuous breathing 
of a mixture of 79% perfluoropropane (PFP) and 21% O2. 3D UTE and gradient echo 
images were acquired during separate 15 second breath-holds. Similar imaging was 
performed in a custom-built resolution phantom filled with either 100% sulphur 




Results: The mean whole-lung signal-to-noise ratio (SNR) in healthy volunteers was 
significantly greater for UTE than for gradient echo imaging (p = 0.04). The mean SNR 
was 27 ± 12 for UTE, and 16 ± 6 for gradient echo imaging. This trend was also 
confirmed by phantom imaging. 
 
Conclusion: Although the SNR was higher in 3D UTE images, 3D gradient echo lung 
images qualitatively appeared to show more detail and had better edge definition. 
Overall, this preliminary study demonstrates that high quality 19F MR images of inert 




Pulmonary fluorine-19 (19F) magnetic resonance imaging (MRI) using inert fluorinated 
gases has recently received increased attention, as it can potentially be applied to patients 
with lung diseases for non-invasive and longitudinal imaging (1). Inert fluorinated gases 
may be able to provide functional lung information that is similar to hyperpolarized noble 
gas MRI, without the need for expensive polarizer equipment (2). Inert fluorinated gases, 
such as tetrafluoromethane (CF4), sulphur hexafluoride (SF6), hexafluoroethane (C2F6), 
and perfluoropropane (C3F8 or PFP) are nontoxic, abundant, and inexpensive. Due to the 
high natural abundance (100%) and high gyromagnetic ratio of 19F, there is sufficient 
thermally polarized signal for imaging. The T1 of PFP has been previously measured to 
be 12.4 ms in human lungs at 3 T, which allows for the use of fast repetition times and 
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averaging within a single breath-hold (3). The first demonstration of inert fluorinated gas 
MRI was reported over 30 years ago by Heidelberger, Lauterbur and colleagues, and this 
technique initially used CF4 to acquire 
19F MR images of excised rabbit lungs (4) and 
healthy dog lungs (5,6). In 1998, Kuethe et al. demonstrated high resolution 3D imaging 
of rat lungs (7), and since that time, the measurement of various functional biomarkers 
has been explored, such as wash-in/wash-out kinetics (8-12), volume measurements (13), 
apparent diffusion coefficients (ADCs) (14-16), and ventilation/perfusion ratios (17,18).  
 
Inert fluorinated gas MR imaging in human lungs was first demonstrated using SF6, when 
Wolf et al. reported 2D whole lung projection images with a relatively low signal-to-
noise ratio (SNR) (19). More recently, Halaweish et al. reported 3D gradient echo MR 
images using inhaled PFP in healthy volunteers, and patients with chronic obstructive 
pulmonary disease (COPD), asthma, or post lung transplantation (20). Recently, Couch et 
al. demonstrated substantial improvements in the image signal-to-noise ratio (SNR) using 
static breath-hold 3D ultrashort echo time (UTE) imaging of healthy volunteers following 
continuous breathing of a PFP/O2 mixture, and a subsequent 15 s breath-hold (3). Since 
the T2
* of PFP was measured to be 2.2 ms in human lungs at 3T, the use of UTE 
acquisition techniques may be a promising alternative to gradient echo imaging (3). 
However, UTE imaging of inert fluorinated gases in the lungs results in significant image 
blurring and lack of edge detail (3), whereas gradient echo imaging tends to provide 
superior edge detail but suffers from a lower SNR due to the longer TE (20). Since the 
preliminary work published thus far has involved stand-alone studies using different 
image acquisition techniques, it remains to be determined what type of image acquisition 
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will provide the highest image quality. The purpose of this study was to perform 19F 3D 
MR imaging using inert fluorinated gases in both a resolution phantom and in the lungs 
of healthy volunteers, and to compare the image quality from images that were obtained 




3.3.1 Phantom Measurements 
All phantom and human lung imaging was performed at 3 T (Philips Achieva, Best, The 
Netherlands) using a flexible wrap-around quadrature transmit/receive coil (Clinical MR 
Solutions, Brookfield, WI) tuned to the 19F resonance frequency (120.15 MHz at 3 T). A 
hollow custom-built resolution phantom was filled with either 100% SF6 or a mixture of 
79% PFP and 21% O2 (Air Liquide, Plumsteadville, PA). A schematic diagram of the 
resolution phantom is shown in Figure 3-1. The resolution phantom had an outer diameter 




* was measured in the resolution phantom for both gas types using a single free 
induction decay (FID) following a 90° pulse. The real component of the FID was phase 
corrected and fitted to an exponential decay function using a non-linear least squares 





Figure 3-1: Schematic diagram of the resolution phantom that was used for SF6 and PFP imaging. The 
outer diameter was 126 mm, and the diameters of the circular obstructions are shown. 
 
19F 3D UTE, gradient echo and radial images were acquired with the following settings: 
TR = 20 ms, matrix = 128 x 128, 7 slices, in-plane FOV = 200 x 200 mm2, 15 mm 
thickness, flip angle = 90°, and bandwidth = 140 or 200 Hz/pixel. The TE for each case is 
shown in Table 3-1. Both gradient echo and radial imaging used the same partial echo 
factor of 62.5%. The number of averages was set to yield similar scan durations for each 
acquisition: 12 averages for UTE, 49 averages for gradient echo, and 31 averages for 
radial. SNR was measured in all UTE, gradient echo, and radial images using Matlab 
R2011a (The Math-Works, Natick, MA). SNR was defined as the mean signal value from 
the largest possible rectangular region of interest (ROI) inside the phantom, divided by 












140 0.13 1.63 1.51 
200 0.14 1.36 1.25 
 
3.3.2 Subjects 
This study protocol was approved by the local research ethics board and by Health 
Canada. All subjects provided written informed consent prior to their participation in this 
study. Five healthy volunteers (4 female and 1 male) were enrolled in this study with no 
history of chronic or current respiratory disease, and no smoking history. The mean age 
of all volunteers (±standard deviation) was 30 ± 15 years. The women had a mean age of 
23.5 years, and the male volunteer was 57 years of age. Digital pulse oximetry was used 
to monitor SpO2 for all subjects during scanning sessions (Veris, Medrad, Warrendale, 
PA).  
 
Conventional 1H MR images were first acquired while the subject was lying in the 
actively decoupled 19F coil. 2D multi-slice gradient echo 1H images were acquired during 
a 1 L breath-hold of air, and with the following settings: TR = 50 ms, TE = 1.49 ms, 
matrix = 128 x 128, 12 slices, in-plane FOV = 450 x 450 mm2, 15 mm thickness, 1.5 mm 
slice gap, flip angle = 11.5°, and bandwidth = 500 Hz/pixel. Prior to 19F imaging, subjects 
breathed continuously from a 5 L Tedlar bag (Jensen Inert Products, Coral Springs, FL) 
of a mixture of 79% PFP and 21% O2. Subjects were instructed to breathe continuously 
until the bag was empty, by inhaling a normal tidal volume of gas from the 5 L bag, and 
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exhaling around the tube. Once empty, the 5 L Tedlar bag was immediately replaced with 
a full 1 L bag of the same mixture of 79% PFP and 21% O2; from FRC, the subjects were 
instructed to completely inhale the 1 L bag and hold their breath for 15 s during image 
acquisition.  
 
For both 19F 3D UTE and 3D gradient echo imaging, the scan duration was limited to a 
single 15 s breath-hold. 19F 3D UTE imaging used the following settings: TR = 20 ms, 
TE = 0.2 ms, matrix = 64 x 64, 12 slices, in-plane FOV = 450 x 450 mm2, 15 mm 
thickness, flip angle = 70°, 75% radial sampling density, 1 average, bandwidth = 140 or 
200 Hz/pixel, and scan duration = 15 s. 19F 3D gradient echo images were acquired with 
the following settings: TR = 27 ms, TE = 1.12 ms, matrix = 64 x 64, 12 slices, in-plane 
FOV = 450 x 450 mm2, 15 mm thickness, flip angle = 70°, partial echo factor = 62.5%, 2 
averages, bandwidth = 200 Hz/pixel, and scan duration = 15 s. Whole-lung SNR was 
measured in all 3D lung images, by manually setting a threshold to separate the lungs 
from the surrounding background and dividing the mean whole-lung signal value by the 
standard deviation of an ROI in the background. Whole-lung SNR measurements from 
19F 3D UTE and 3D gradient echo lung images were compared using a two-tailed paired 






Figure 3-2(a) shows 19F MR images for the resolution phantom filled with PFP from 
gradient echo, UTE, and radial acquisitions at bandwidths of 140 and 200 Hz/pixel. The 
T2
* of PFP was measured to be 5.1 ms in the resolution phantom, which led to a similar 
SNR for gradient echo and UTE imaging. Figure 3-2(b) shows SF6 resolution phantom 
images from gradient echo, UTE, and radial acquisitions at bandwidths of 140 and 200 
Hz/pixel. The T2
* of SF6 was measured to be 1.2 ms in the resolution phantom, which led 
to a higher SNR for UTE compared to gradient echo imaging.  
 
Figure 3-2: Comparison of one slice from 3D images that were obtained in a resolution phantom filled 
with a mixture of (a) 79% PFP and 21% O2 or (b) 100% SF6. Images were acquired using (i) gradient echo, 




Table 3-2 shows the mean SNR measurements for all of the images shown in Figure 3-2. 
The error in Table 3-2 represents the standard deviation of SNR measurements in the 5 
most central slices. In order to make a fair comparison between UTE, gradient echo, and 
radial imaging, the SNR was normalized by the square root of the scan duration.  
Table 3-2: PFP and SF6 Resolution Phantom Measurements. Mean SNR (± standard deviation) from all 19F 












140 11.9±0.4 11.6±0.5 8.1±0.3 12.7±0.7 6.4±0.3 4.6±0.2 
200 8.3±0.3 10.1±0.4 6.7±0.2 8.9±0.4 6.5±0.3 4.8±0.2 
 
In order to demonstrate the resolving power of PFP and SF6 imaging in the resolution 
phantom, Figure 3-3 shows examples of 1D profiles taken from images in Figure 3-2 
acquired at a bandwidth of 200 Hz/pixel. Horizontal profiles were chosen such that signal 
changes due to the 3 mm and 10 mm circular obstructions could be visualized.  
 
Figure 3-3: 1D profiles taken from PFP (left) and SF6 (right) images acquired in the resolution phantom at 
a bandwidth of 200 Hz/pixel. Note that the horizontal signal profiles for gradient echo, UTE, and radial 
imaging were offset for visual clarity. The white arrow indicates the 3 mm obstruction, and the black arrow 


































In general, PFP appears to visualize small features in the resolution phantom very well, 
whereas for SF6 the 3 mm obstruction is only visible in gradient echo imaging. 
 
Table 3-3 summarizes the results from all five healthy volunteers, including the whole-
lung SNR measurements from all 19F UTE and gradient echo images acquired in the 
coronal plane. For SNR, the error represents the heterogeneity of 19F signal throughout 
the entire lungs. Since the imaging parameters for both UTE and gradient echo were 
adjusted to keep the scan duration to within a 15 s breath-hold, the SNR values were not 
normalized in Table 3-3.  
 
Table 3-3: Human Lung Imaging. Mean whole-lung SNR (± standard deviation) from all available 19F 3D 






a For subject #4, gradient echo images were acquired with TR = 18 ms and NSA = 3. 
b For subject #5, UTE images were acquired with FOV = 400 x 400 mm2, TR = 16 ms and 92% angular 
sampling density. 
c For subject #5, gradient echo images were acquired with FOV = 400 x 400 mm2, TR = 16 ms, TE = 1.09 
ms and NSA = 3.  
 
For 19F 3D UTE images at a bandwidth of 140 Hz/pixel, the mean whole-lung SNR was 
27 ± 12, while for 3D gradient echo images, the mean SNR was 16 ± 6. Overall, the 
whole lung SNR from UTE images at a bandwidth of 140 Hz/pixel was significantly 









1 f 27 11 ± 5 9 ± 3 8 ± 3 
2 f 24 40 ± 21 - 23 ± 10 
3 m 57 40 ± 17 - 18 ± 7 
4 f 23 29 ± 12 20 ± 8 20 ± 13a 
5 f 20 17 ± 9b 14 ± 6b 14 ± 6c 
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higher than gradient echo images at a bandwidth of 200 Hz/pixel (p = 0.04). Since UTE 
images at 200 Hz/pixel were only acquired in three subjects, the SNR was not statistically 
different from the UTE images at 140 Hz/pixel or the gradient echo images at 200 
Hz/pixel. 
 
Figure 3-4 shows a comparison of 4 central slices in the coronal plane from a 1H 
localizer, 19F 3D UTE, and 19F 3D gradient echo lung images that were acquired from 
subject #3. The whole-lung SNR was 40 ± 17 and 18 ± 7, for the coronal 3D UTE and 3D 
gradient echo images shown in Figure 3-4, respectively.  
 
 
Figure 3-4: Comparison of four central slices from lung images in the coronal plane acquired in subject #3 
in the same imaging session: (a) 1H localizer, (b) 19F 3D UTE, and (c) 19F 3D gradient echo. The UTE 
images were reproduced with permission (3). 
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Figure 3-5 shows a similar comparison of 4 central slices in the axial plane from a 1H 
localizer, 19F 3D UTE and 19F 3D gradient echo lung images that were acquired from 
subject #2. The whole-lung SNR was 29 ± 13 and 21 ± 9, for the axial 3D UTE and 3D 
gradient echo images shown in Figure 3-5, respectively.  
 
 
Figure 3-5: Comparison of four central slices from lung images in the axial plane acquired in subject #2 in 
the same imaging session: (a) 1H localizer, (b) 19F 3D UTE, and (c) 19F 3D gradient echo. The UTE images 
were reproduced with permission (3). 
 
Figure 3-6 shows a comparison of center slice coronal and axial images that were 
acquired using UTE and gradient echo overlaid in colour on 1H localizer images. Since 
Figure 3-6 clearly shows the boundary of the thoracic cavity, the blurring effects in UTE 





Figure 3-6: Comparison of centre slice coronal (left) and axial (right) MR lung images from 19F 3D UTE 
(top) and 19F 3D gradient echo (bottom) overlaid in colour on conventional 1H MR images. The coronal 
images were acquired in subject #3, while the axial images were acquired in subject #2. 
 
3.5 Discussion 
Phantom imaging was initially performed using the same mixture of 79% PFP and 21% 
O2 that was used for human lung MR imaging. UTE and gradient echo resolution 
phantom images had very similar SNRs for PFP, and both techniques had the same 
resolving power as all five circular obstructions were visible at both 140 and 200 
Hz/pixel. However, the T2
* of PFP in the resolution phantom was substantially longer 
than the T2
* of PFP in human lungs (5.1 ms compared to 2.2 ms) (3) and also much 
longer than any of the TEs used in this study (up to a maximum of 1.63 ms), and 
therefore, the phantom measurements made using PFP could not be fairly compared to 
human lung imaging. On the other hand, the T2
* of SF6 was measured to be 1.2 ms in the 
resolution phantom, which was closer to the T2
* of PFP in the lungs. For the case of SF6, 
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UTE resolution phantom images had the highest SNR, compared to gradient echo and 
radial imaging. The UTE SNR also benefited from a lower bandwidth, at the expense of 
increased blurring due to the short T2
* and longer acquisition window.  
 
SF6 gradient echo images at a bandwidth of 200 Hz/pixel had the highest resolving 
power, as all five circular obstructions were visible (as small as 3 mm in diameter). SF6 
UTE images had a lower resolving power, as only four circular obstructions were visible 
at both 140 and 200 Hz/pixel (as small as 5 mm in diameter). Since all five circular 
obstructions were visible in all cases with PFP, the SF6 phantom images confirm that T2
* 
decay is the main reason for blurring in the case of a short T2
* (such as PFP in human 
lungs). Radial imaging was also performed in the resolution phantom to provide a point 
of reference that had similar k-space sampling to UTE, and also had the same partial echo 
factor as gradient echo imaging (62.5%). Since radial imaging had a lower SNR than both 
UTE and gradient echo imaging, it is clear that gradient echo benefits from a uniform k-
space sampling, and UTE benefits even more from having a very short TE.  
 
Human imaging showed a trend similar to phantom imaging, as the UTE images had a 
statistically greater SNR than gradient echo images (p = 0.04). For subject #2, the SNR in 
the center slices of coronal 3D UTE images was 43% higher than 3D gradient echo 
images. An improvement in SNR was expected, since the UTE acquisition had a much 
shorter TE than gradient echo imaging (0.2 ms compared to 1.12 ms). Assuming a T2
* of 
2.2 ms in the lungs (3), the difference in TE alone should theoretically lead to a 52% 
difference in SNR. In addition to the increased SNR in UTE images, substantial blurring 
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was apparent due to the short T2
* of PFP in combination with a long acquisition window 
at a bandwidth of 140 Hz/pixel (22). On the other hand, gradient echo images had a lower 
SNR, but they also had better edge definition than UTE images. For the purposes of 
comparing image quality for UTE and gradient echo imaging, both acquisitions were 
limited to a 15 second scan duration. Although the two acquisition techniques had 
different k-space sampling strategies, the breath-hold length constrained how much 
sampling could occur within a single image acquisition and holding this parameter 




In conclusion, this preliminary study demonstrates that high quality 19F MR images of 
inert fluorinated gases in human lungs can be obtained using either a 3D UTE or 3D 
gradient echo method. Although the SNR is higher in UTE images, gradient echo images 
qualitatively appear to show more detail and have better edge definition. Once fully 
optimized, this technique may have significant advantages over hyperpolarized noble gas 
MRI, since it is inexpensive, the gases are abundant, there is a sufficiently high thermal 
polarization for imaging, and the technique can be performed on any MRI scanner with 
broadband capability. Overall, inert fluorinated gas MRI has the potential to be a viable 
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4 Preliminary Measurements of Functional Biomarkers Using 19F MRI of Inert 
Fluorinated Gases 
Preliminary Measurements of Functional 




Chapters 2 and 3 have discussed preliminary developments in inert fluorinated gas MRI, 
where UTE and gradient echo imaging was performed in healthy volunteers. This 
imaging was performed during 15 second breath-holds, which provides a static 
“snapshot” of ventilation function. The resulting images were able to visualize the 
distribution of the inhaled gas, and future imaging in patients with respiratory diseases is 
expected to yield the characteristic patterns of ventilation defects. In addition to the static 
breath-hold imaging that has already been presented, inert fluorinated gas MRI can also 
be used to measure functional biomarkers that can provide sensitive and quantitative 
diagnostic information. 
 
This chapter consists of three brief studies that investigated the potential for using inert 
fluorinated gas MRI to measure functional image-derived biomarkers. The first study 
performed volume measurements in healthy volunteers to derive the ventilated volume 
(VV), the ventilation defect volume (VDV), and the ventilation defect percent (VDP). In 
order to provide a baseline for comparison, these results were compared to similar 
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volume measurements that were obtained using HP 3He MRI. Although ventilation 
defects are expected to be small in healthy volunteers, validating these measurements is 
an important step towards imaging patients with respiratory diseases.  
 
The second study in this chapter presents preliminary measurements of inert fluorinated 
gas apparent diffusion coefficients (ADCs) in a single healthy volunteer. The ADC is a 
biomarker that is sensitive to microstructural changes in the lungs, such as the destruction 
of alveolar walls in emphysema. The final study in this chapter investigates gravitational 
gradients in ventilation using inert fluorinated gas MRI. Gravitational gradients were 
evaluated in a group of healthy volunteers, and these results agreed with expectations 
based on known patterns in lung physiology. Overall, the image-derived biomarkers 
presented in this chapter have the potential yield valuable insight into lung function and 
disease severity. Future studies using these techniques in patients with lung diseases will 
to help evaluate the diagnostic abilities of inert fluorinated gas MRI. 
 
4.2 Volume Measurements and Comparison to HP 3He MRI 
 
4.2.1 Introduction 
Fluorine-19 (19F) magnetic resonance imaging (MRI) of the lungs using inhaled inert 
fluorinated gases is a technique currently under development that can potentially provide 
images of the distribution of pulmonary ventilation, similar to hyperpolarized (HP) noble 
gas MRI. Inert fluorinated gases, such as sulfur hexafluoride (SF6) and perfluoropropane 
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(C3F8 or PFP), have several potential advantages over HP gases, as they are nontoxic, 
abundant, and inexpensive. MR imaging of thermally polarized inert fluorinated gases is 
made possible due to the high gyromagnetic ratio and high natural abundance of 19F. 
Furthermore, the short longitudinal relaxation times of inert fluorinated gases allows for 
many signal averages within a single breath-hold. Therefore, pulmonary 19F MRI is 
possible without the expensive polarizer and scarce isotopes that are required for HP gas 
MRI.  
 
Inert fluorinated gas MR imaging of the lungs has been previously demonstrated in a 
number of animal studies (1-3), and more recent work has demonstrated imaging in 
healthy volunteers (4) and in patients with lung diseases such as chronic obstructive 
pulmonary disease (COPD), asthma, and lung transplants (5). The work to date has been 
performed in stand-alone studies using various imaging techniques and different 
parameters to optimize the image quality. As interest in this new pulmonary imaging 
technique is growing, validation studies and comparisons to existing pulmonary imaging 
techniques will be required in order to consider all factors that contribute to image 
features and image quality, including the physical properties of these heavy fluorinated 
gases. Therefore, the goal of the present study was to perform a quantitative comparison 
between lung images obtained using inert fluorinated gas MRI and HP 3He MRI in the 




4.2.2 Methods  
This study protocol was approved by the local research ethics board and by Health 
Canada. All subjects provided written informed consent prior to their participation in this 
study. Five healthy female volunteers (mean age = 23 ± 3 years) were enrolled in this 
study with no previous history of lung disease and no previous history of smoking. All 
imaging in this study was performed using a 3 T scanner (Philips Achieva, Best, The 
Netherlands) and two flexible wrap-around quadrature transmit/receive coils tuned to 
either the 3He or 19F resonance frequencies (Clinical MR Solutions). Conventional 1H 2D 
multi-slice gradient echo images were initially acquired using a 1 L breath-hold of air 
with the following settings: TR = 50 ms, TE = 1.49 ms, matrix = 128 x 128, 12 slices, in-
plane FOV = 450 x 450 mm2, 15 mm thickness, 1.5 mm slice gap, flip angle = 11.5°, and 
bandwidth = 500 Hz/pixel. Conventional 1H images were obtained in both the coronal 
and axial planes to facilitate planning 3He and 19F image acquisitions.  
 
3He was polarized using spin-exchange optical pumping (SEOP) in a custom-built 
polarizer. After approximately 18 hours of optical pumping, the 3He polarization was 
about 15%. HP 3He MR images were acquired following inhalation of a 1 L bag 
containing 330 mL of HP 3He balanced to 1 L with N2. HP 
3He images were obtained 
during a 15 s breath-hold using a 2D multi-slice gradient echo method in the coronal 
plane with the following settings: TR = 56 ms, TE = 1.53 ms, matrix = 128 x 64 
reconstructed to 256 x 256, 14 slices, in-plane FOV = 450 x 450 mm2, 15 mm thickness, 




19F images were obtained during a 25 s breath-hold using either a 3D ultrashort echo time 
(UTE) or 3D gradient echo acquisition that followed several wash-out breaths of a 
mixture of 79% PFP and 21% O2. 
19F 3D UTE imaging used the following settings: TR = 
20 ms, TE = 0.2 ms, matrix = 64 x 64, 12 slices, in-plane FOV = 450 x 450 mm2, 15 mm 
thickness, flip angle = 70°, 75% radial sampling density, and BW = 200 Hz/pixel. 19F 3D 
gradient echo images were acquired with the following settings: TR = 16 ms, TE = 1.08 
ms, matrix = 64 x 64, 12 slices, in-plane FOV = 450 x 450 mm2, 15 mm thickness, flip 
angle = 70°, 5 averages, and BW = 200 Hz/pixel.  
 
The signal-to-noise ratio (SNR) was measured for all 19F and 3He images using custom-
built software written in Matlab R2011a (The Math-Works, Natick, MA). The semi-
automated segmentation algorithm of Kirby et al. (7) was used to calculate the VV, VDV, 
and VDP for all 19F and 3He images. Figure 4-1 shows a schematic diagram of the semi-
automated segmentation algorithm. The first step in the algorithm is to segment the 
ventilation image using k-means clustering, which separates the image into five distinct 
clusters with gradations in signal intensity from no signal (cluster 1) and low signal 
(cluster 2) to high signal (cluster 5). Next, the thoracic cavity is segmented from the 
conventional 1H MR image using a seeded region-growing method. The ventilation 
image is then overlaid on the segmented thoracic cavity using a landmark-based 
registration method. Following image segmentation, the VDV is then calculated by 
multiplying the number of voxels in cluster 1 by the volume occupied by each voxel. 
Similarly, the VV is the sum of the voxels in clusters 2 through 5 multiplied by the 




Figure 4-1: Schematic diagram of the semi-automated segmentation algorithm. Images were reproduced 
with permission from Kirby et al. (7). 
 
The VDP is essentially the VDV normalized to the thoracic cavity volume (TCV), and it 




∙ 100% =  
𝑉𝐷𝑉
𝑉𝑉 + 𝑉𝐷𝑉
∙ 100% [4-1] 
The SNR and volume measurements were compared between HP 3He and 19F imaging 
using a two-tailed paired t-test in GraphPad Prism (GraphPad Software, La Jolla, CA), 
where p < 0.05 was considered to be significant. 
 
4.2.3 Results  
Figure 4-2 shows a comparison of 4 central coronal slices that were obtained using a 
conventional 1H localizer, a HP 3He 2D multi-slice gradient echo, a 19F 3D gradient echo, 
and a 19F 3D UTE in subject #4. Qualitatively, the HP 3He images clearly have a superior 
SNR, and images can easily be acquired at a much higher resolution than the inert 
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fluorinated gas images. The HP 3He images also show more fine detail, such as the major 
airways and pulmonary vasculature. On the other hand, the image quality from inert 
fluorinated gas imaging appears promising, in spite of the fact that SNR is clearly lower 
than HP 3He imaging. 
 
 
Figure 4-2: Comparison of representative (a) 1H localizer, (b) 3He 2D gradient echo, (c) 19F 3D gradient 





A summary of the measured SNR from all HP 3He and 19F images is shown in Table 4-1. 
Note that the type of image acquisition used for 19F MRI is indicated. The HP 3He SNR 
was significantly greater than the SNR from inert fluorinated gas imaging (p = 0.01). The 
HP 3He SNR ranged from 39 to 75, while the inert fluorinated gas SNR ranged from 8 to 
18. Variability in the HP 3He SNR can be explained by day-to-day variability in polarizer 
performance, while variability in the inert fluorinated gas SNR can be explained by 
variations in coil calibration due to body size as well as subject compliance with regard to 
taking multiple breaths of the fluorinated gas mixture.  







Table 4-2 summarizes the volumetric measurements that were obtained from three 
subjects in this study. Two of the five subjects in this study were not included in the 
volume measurements, since a larger slice thickness was used in those cases (22 mm 
compared to 15 mm). For the 3 subjects shown in Table 4-2, the VV, VDV, and VDP 
measurements were not statistically different between HP 3He MRI and inert fluorinated 
gas MRI (p > 0.05). 
  
Subject 3He SNR 19F SNR 19F Sequence 
1 72 ± 37 18 ± 8 3D UTE 
2 99 ± 50 8 ± 3 3D UTE 
3 75 ± 36 8 ± 2 3D UTE 
4 40 ± 18 
16 ± 6 3D Gradient Echo 
15 ± 6 3D UTE 
5 39 ± 16 9 ± 4 3D Gradient Echo 
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Table 4-2: Comparison of VV, VDV and VDP measurements obtained from 3He and 19F MR imaging in 
the lungs of three subjects. 
 3He 19F 
Subject VV (L) VDV (L) VDP (%) VV (L) VDV (L) VDP (%) 
3 3.8 0.11 2.9 3.34 0.55 14.14 
4 4.9 0.28 5.35 
6.13 0.55 8.3 (GE) 
5.33 0.24 4.29 (UTE) 
5 5.33 0.27 4.83 5.05 0.59 10.5 
 
4.2.4 Discussion 
This preliminary study demonstrates, for the first time, a quantitative comparison 
between HP 3He MRI and inert fluorinated gas MRI in the same healthy volunteers. In 
order to assess the images that were produced by these two techniques, SNR and 
volumetric parameters were measured. As expected, the SNR was significantly larger for 
HP 3He MRI compared to inert fluorinated gas imaging. At this point in time, 19F images 
do suffer from a poor resolution, poorly defined edges, and T2
*-induced blurring is 
particularly apparent in the 19F UTE images. The image quality of inert fluorinated gas 
MRI will continue to be improved with the use of phased array coils (8,9), as well as 
novel and efficient image acquisition techniques, such as x-centric (3); however, there is 
a possibility that the current image quality of inert fluorinated gas imaging is sufficient 
for diagnostic decision making. Future comparisons in patients with pulmonary diseases, 
such as asthma and COPD, will help to determine the true clinical potential of inert 
fluorinated gas MRI.  
 
The VV, VDV, and VDP measurements from HP 3He and inert fluorinated gas imaging 
were statistically indistinguishable in this preliminary study. As expected, the VV 
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measurements were similar for both techniques in most cases, since imaging was 
performed at approximately FRC + 1 L. In most cases, the VDV and VDP were slightly 
larger for inert fluorinated gas imaging compared to 3He MRI. This result may be 
explained by a lower SNR and poorly defined edges, or it may be related to differences in 
the physical properties of the inhaled gases. That is, the density and diffusivity of PFP 
will be important in interpreting the size of ventilation defects, as a recent comparison of 
VDV measurements performed using HP 3He and HP 129Xe MRI in COPD patients 
demonstrated a significantly greater VDV as measured from HP 129Xe MRI. It was 
suggested that these apparent differences in VDV might be related to the higher density 
and lower diffusivity of 129Xe, which might lead to slower filling in the terminal airways, 
and hence, larger apparent ventilation defects (10).  
 
Although it may be reasonable to assume that the high density and low diffusivity of inert 
fluorinated gases will lead to large apparent ventilation defects in patients with 
pulmonary diseases, it is also possible that the use of continuous breathing might offset 
these effects. That is, continuous breathing prior to imaging allows for a steady-state 
concentration of the inert fluorinated gas to be reached, which may compensate for the 
slow filling of heavy gases and make ventilation defects appear smaller. Ultimately, the 
context of the measurement will need to be taken into account in order to properly 
interpret the size of ventilation defects. Furthermore, an accurate measurement of VV and 
VDV using inert fluorinated gas MRI may require corrections for B1 inhomogeneity (11). 
Naturally, many more subjects will be required in order to fully validate inert fluorinated 
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gas imaging, as well as future comparisons in patients with pulmonary diseases to 
determine if the volume measurements yield clinically meaningful results. 
 
4.2.5 Conclusions  
Although the SNR from inert fluorinated gas MR lung images was less than HP 3He 
imaging, the lung volume measurements in this preliminary study were statistically 
indistinguishable between the two techniques. Therefore, inert fluorinated gas MRI has 
the potential to yield meaningful functional information that is similar to HP 3He MRI. 
Future comparison studies in additional subjects and in patients with pulmonary diseases 
will determine if inert fluorinated gas MRI can become a viable clinical imaging 
modality that can aid in diagnostic decision making.  
 
4.3 Diffusion Imaging 
 
4.3.1 Diffusion Physics 
Brownian motion refers to the random movement of particles, and this phenomenon was 
famously described by Einstein in one of his ground-breaking 1905 papers (12). An atom 
or molecule undergoing a random walk will travel a root mean squared distance, σ, that is 
given by the following equation in three dimensions: 
 𝜎 = √6 ∙ 𝐷0 ∙ ∆. [4-2] 
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where Δ is the diffusion time and D0 is the self-diffusion coefficient. For example, a gas 
such as 3He has a self-diffusion coefficient of 2.05 cm2·s-1, and in 1 ms, it will travel a 
root mean squared distance of 1.1 mm. In air, 3He has a lower diffusion coefficient of 
0.86 cm2·s-1 (due to collisions with larger gas molecules), and it would travel a root mean 
squared distance of 0.72 mm in 1 ms. 
 
In a restricted environment, such as porous media and lung tissue, the actual distance the 
atom or molecule travels is limited by the geometry of the container. For example, human 
alveoli have an approximate diameter of 200 μm (13), and therefore, this physical 
boundary would reduce the measured diffusion coefficient of 3He at diffusion times on 
the order of a few milliseconds. In this regime, the measured diffusion coefficient is 
referred to as the apparent diffusion coefficient (ADC).  ADC can be measured in MRI 
by encoding the diffusion information with the application of bipolar diffusion-
sensitizing gradients prior to the signal readout. For example, Figure 4-3 shows a basic 
2D gradient echo acquisition with diffusion sensitization along the phase encoding 
direction. The time between the leading edges of the bipolar diffusion-sensitizing 
gradient lobes is defined as the diffusion time, Δ. In principle, diffusion sensitization can 




Figure 4-3: Pulse sequence diagram for a 2D gradient echo acquisition with diffusion sensitization along 
the phase encoding direction. 
 
In Figure 4-3, the total area underneath the bipolar diffusion-sensitizing gradients is zero, 
which means that any phase accumulated during this time is due to Brownian motion 
only. Therefore, the diffusion-induced signal decay can be expressed in the following 
way: 
 𝑆 = 𝑆0 ∙ 𝑒
−𝑏∙𝐴𝐷𝐶, [4-3] 
where 𝑆0 is the original signal without diffusion sensitization, 𝑆 is the signal with 
accumulated phase due to diffusion sensitization, and 𝑏 is a parameter characterizing the 
amount of diffusion sensitization in units of s·cm-2. A simple rearrangement of the 








Therefore, at least two measurements are required in order to calculate the ADC: one 
image with diffusion sensitization, and one without (i.e. b = 0).  
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4.3.2 Diffusion Measurements in the Lung 
In conventional 1H MRI, diffusion-weighted imaging (DWI) is typically used to measure 
the ADC of water molecules, and there are numerous applications such as diffusion 
tensor imaging (DTI) and tractography (14). In the context of the lungs, DWI of gases 
uses essentially the same basic principles; however, the diffusion coefficients of gases are 
typically several orders of magnitude larger than the diffusion coefficient of water. Table 
4-3 lists the diffusion coefficients of 3He, 129Xe, PFP and SF6, and for comparison, the 
self-diffusion coefficient of water is approximately 2·10-5 cm2·s-1 at room temperature 
(15). Generally speaking, 3He is a very light gas that has a relatively high diffusion 
coefficient, while the inert fluorinated gases are very heavy and have the lowest diffusion 
coefficients. The diffusion coefficient of 129Xe is somewhat between 3He and the 
fluorinated gases. 
 
Table 4-3: Diffusion coefficients for 129Xe, 3He, PFP, and SF6, in units of [cm2·s-1] (16-18). 
Parameter 129Xe 3He PFP SF6 
Self-diffusion coefficient, D0 0.061 2.05 0.023 0.033 
Diffusion coefficient in air, D 0.14 0.86 0.071 0.094 
 
HP noble gas ADC measurements performed using 3He and 129Xe are well-known to be 
sensitive to the lung microstructure, and these measurements can distinguish between 
healthy and emphysematous tissue (19,20). That is, a higher ADC can be measured in 
patients with emphysema, and this difference can be explained by enlarged alveoli caused 
by the destruction of alveolar walls. HP gas ADC measurements have been shown to be 
reproducible (21), and ADCs have been correlated with spirometric indices, such as FEV1 
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and FVC. ADC measurements have also been successfully validated with a comparison 
to standard histological measurements, such as the surface to volume ratio (S/V) and 
mean linear intercept (Lm) (22).  
 
HP gas ADC is also able to measure morphological parameters by acquiring images at 
multiple b values and fitting to geometrical models, such as the model of Yablonskiy et 
al. (23,24). The Yablonskiy model is able to measure physical parameters that are related 
to anisotropic diffusion and the geometry of acinar airways, and this model has also been 
successfully validated with a comparison to histology (25). Due to the exceedingly high 
cost and limited availability of 3He, HP 129Xe MR imaging has received increased 
attention recently and the literature has focused on developing HP 129Xe ADC (20) and 
validating these measurements with a comparison to HP 3He MRI (10,26).  
 
Preliminary inert fluorinated gas ADC measurements are currently underway, and this 
technique may be able to provide similar information to HP noble gas MRI. The first 
demonstration of inert fluorinated gas ADC measurements was performed in healthy rats 
using SF6, and the measured ADC was slightly less than the self-diffusion coefficient of 
SF6 (18,27). An elastase-induced model of emphysema in rats was employed to help 
determine whether this technique had a potential to detect pulmonary disease, and 
elevated C2F6 ADC values were detected in emphysematous regions of rat lungs (28). 
Significant differences in C2F6 ADC values were also detected in a study of healthy and 
emphysematous excised human lungs (29,30), which was an important first step towards 
translating this technique to human imaging. 
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4.3.3 Preliminary 19F ADC Measurements in Human Lungs 
Despite the challenges of imaging fluorinated gases with very short T2* values, it is 
possible to probe ADCs in humans using a UTE approach in combination with bi-polar 
diffusion-sensitizing gradients (31). As an example, Figure 4-4 shows two sets of 19F 3D 
UTE lung images that were acquired in a healthy volunteer during a single 15 second 
breath-hold of a mixture of 79% PFP and 21% O2
*. Similar to the 19F 3D UTE images 
shown in Figure 2-4 and Figure 2-5, imaging followed continuous breathing of the 
PFP/O2 mixture.  
  
Figure 4-4: Three slices from 19F 3D UTE lung imaging acquired in a healthy volunteer (a) without 
diffusion weighting (b = 0 s·cm-2), and (b) with diffusion weighting (b = 9.59 s·cm-2).  
 
                                                 
*
 Inert fluorinated gas ADC results are presented for one healthy volunteer only. This work was part of a 
study protocol that was approved by the local research ethics board and by Health Canada. This subject 
provided written informed consent prior to participating in this study 
a) b = 0 s·cm-2
b)  b = 9.59 s·cm-2
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Each set of 19F 3D UTE images shown in Figure 4-4 consisted of three slices; images 
without diffusion weighting (b = 0 s·cm-2) are shown in the top row, and images with 
diffusion weighting (b = 9.59 s·cm-2) are shown in the bottom row. In order to achieve a 
b value of 9.59 s·cm-2 and diffusion time of 1.5 ms, a TE of 3.8 ms was required. In this 
case, these settings yielded an SNR in the centre slice image of approximately 22 in the 
unweighted image and approximately 18 in the diffusion-weighted image.  
 
The top row in Figure 4-5 shows the PFP ADC maps that were calculated using the 
diffusion-weighted 19F 3D UTE images shown in Figure 4-4. ADC was calculated on a 
pixel-by-pixel basis using Eq. [4-4]. The histograms for each ADC map are shown in the 
bottom row in Figure 4-5.  
 










The mean ADC values from each slice in Figure 4-5 were 0.034 ± 0.021 cm2·s-1, 0.025 ± 
0.016 cm2·s-1, and 0.023 ± 0.011 cm2·s-1, respectively, where the error represents the 
heterogeneity in each respective ADC map. These ADC results were similar to 
previously published values for the diffusion of PFP mixed with O2 (16). This was to be 
expected for a diffusion time of 1 ms and the lightly restricted diffusion length scale that 
was probed. Assuming an ADC of 0.027 cm2·s-1 for PFP mixed with 21% O2 (16), a 
length scale of approximately 0.16 mm will be probed in 1.5 ms, which less than the 
diameter of an alveolus (~0.2 mm) (13). A longer diffusion time would be required to 
reach the restricted diffusion regime that is normally used for HP noble gas 
measurements of ADC. Since longer diffusion times necessitate long TEs, and the T2
* of 
inert fluorinated gases may be prohibitively short, conventional restricted diffusion and 
lung morphometry measurements may not be possible with inert fluorinated gases (32).  
 
However, by probing multiple diffusion times that are less than or on the order of T2
*, it 
may be possible to measure the S/V ratio with inert fluorinated gases, which is an 
important biomarker of lung microstructure. In general, restriction causes the ADC to 
decrease as a function of diffusion time, as shown in Figure 4-6 (30). By acquiring 2 or 
more data points in the linear short time-scale regime, the slope from Figure 4-6 can be 











where 𝐷(𝑡) is the time-dependent ADC. It is also possible to mix inert fluorinated gases 
with other inert gases, such as 4He, to increase the free diffusivity, and hence the 
diffusion length scale that will be probed. Although there are a number of potential 
130 
 
difficulties, inert fluorinated gas diffusion measurements have been demonstrated in 
humans, and there is a possibility for probing the lung microstructure in humans with 
pulmonary diseases. 
 
Figure 4-6: ADC normalized to the self-diffusion coefficient, D(t)/D0, is shown plotted as a function of 
diffusion time, t. Note that the diffusion time is scaled in dimensionless units by making use of the free 
diffusion length scale and the surface-to-volume ratio (S/V). Image reproduced with permission (30). 
 
4.4 Gravitational Distribution of Ventilation 
 
4.4.1 Introduction 
Functional 19F MRI using inert fluorinated gases has already been established as a 
potentially valuable technique for pulmonary imaging, and the measurement of image-
derived biomarkers can provide additional information regarding lung function. One such 
biomarker is the gradient in pulmonary ventilation, which is a well-known phenomenon 
that is caused by a gravitationally-dependent gradient in regional compliance. In order to 
support the weight of the lungs, the intrapleural pressure surrounding the lungs is less 
negative in dependent regions (i.e. regions of the lung that are closer to the ground), 
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which leads to a smaller resting volume. Thus, alveoli in dependent lung regions are on a 
steeper portion of the pressure-volume curve and they are easier to inflate (34). 
Therefore, ventilation is always greater in more dependent regions of the lung.  
 
Gravitationally dependent gradients in ventilation have been previously demonstrated 
using a number of lung imaging techniques, including xenon-enhanced CT (Xe-CT) (35), 
O2-enhanced 
1H MRI (36), and HP noble gas MRI (37,38). Although one study has 
investigated ventilation gradients in healthy rats using inert fluorinated gas MRI (3), a 
gravitational distribution of pulmonary ventilation has not been quantitatively 
demonstrated using 19F MRI in humans. In this brief study, 19F 3D UTE imaging was 
performed in healthy subjects with inert fluorinated gases, and anterior/posterior (A/P) 
ventilation gradients were measured (31,39). 
 
4.4.2 Methods 
This study protocol was approved by the local research ethics board and by Health 
Canada. All subjects provided written informed consent prior to their participation in this 
study. Imaging was performed using a 3.0 T scanner (Philips Achieva, Best, The 
Netherlands) and a flexible wrap-around quadrature transmit/receive coil tuned to the 19F 
resonance frequency of 120.15 MHz (Clinical MR Solutions). Six healthy volunteers (5 
female, 1 male) were enrolled in this study with no previous history of lung disease and 
no previous history of smoking. The mean age of all subjects was 30 ± 13. Subjects were 
imaged in the supine position during a 15 second breath-hold following inhalation of a 
gas mixture of 79% PFP and 21% O2 from a Tedlar bag.  
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For 4 subjects, 19F 3D UTE MR images were acquired in the axial plane following a 1 L 
inhalation of the PFP/O2 mixture with the following settings: TR = 20 ms, TE = 0.2 ms, 
matrix = 64 x 64, 8 slices, 22 mm thickness, in-plane FOV = 450 x 450 mm2, flip angle = 
70°, and bandwidth = 140 Hz/pixel. For 2 subjects, 19F 3D UTE MR images were 
acquired following continuous breathing from a 5 L bag of the PFP/O2 mixture, followed 
by a 1 L inhalation of the same mixture from a separate bag and 15 s breath-hold. For 
these 2 subjects only, 12 slices were acquired with a 15 mm thickness.  
 
The resulting images were analyzed in Matlab R2011a using a custom-built graphical 
user interface (Mathworks, Natick, MA). Each slice in the 3D image was normalized 
such that all slices had similar noise levels. Next, a threshold was manually set to 
separate the lungs from the surrounding background and all slices were summed to create 
a single projection image of the entire lung in the axial plane. The signal intensity was 
then normalized to the maximum signal value in the 2D projection image. The mean 
signal intensity from the final projection image was then plotted as a function of distance 
from the most posterior edge of the lung, and the slope of a linear regression yielded the 
ventilation gradient. 
 
4.4.3 Results and Discussion 
Table 4-4 shows a summary of the measured ventilation gradients from all six healthy 
volunteers, along with the coefficients of determination (R2), and percent changes in 
ventilation along the vertical direction. Qualitatively, there was no apparent difference 
between the ventilation gradients calculated for subjects that inhaled the PFP/O2 mixture 
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as a 1 L bolus (subjects 1 – 4) and subjects that inhaled the PFP/O2 mixture using 
continuous breathing from a 5 L bag followed by a 1 L bolus inhalation and breath-hold 
(subjects 5 and 6).  
Table 4-4: Summary of measured ventilation gradients, coefficients of determination (R2), and percent 
changes in ventilation along the vertical direction for all six healthy volunteers. The first four volunteers 
inhaled the PFP/O2 mixture as a 1 L bolus, and the last two volunteers inhaled the PFP/O2 mixture using 








1 -0.03058±0.00006 0.742 -75.4 
2 -0.04107±0.00006 0.747 -81.2 
3 -0.03315±0.00004 0.635 -80.4 
4 -0.02259±0.00004 0.548 -66.6 
5 -0.03759±0.00005 0.808 -76.6 
6 -0.03325±0.00003 0.928 -84.2 
 
Figure 4-7(a) shows one example of a whole lung axial projection image that was 
obtained from a representative 19F 3D UTE image that was acquired in the axial plane in 
subject #6. Figure 4-7(b) shows the signal intensity from the image shown in Figure 
4-7(a) plotted as a function of vertical distance from the dorsal surface of the lung. The 
solid line in Figure 4-7(b) represents the calculated ventilation gradient, which has a 
slope of -0.033 cm-1; this gradient represents an 84% change in signal intensity from the 





Figure 4-7: (a) Whole lung axial projection 19F MR image acquired in a representative healthy volunteer. 
(b) Signal intensity as a function vertical distance in the lungs. The solid line represents the calculated 
gradient. Images were reproduced with permission (31). 
 
Although this preliminary data appears to demonstrate the expected gradient in the 19F 
signal, it is difficult to compare these results to literature values, which generally quantify 
fractional ventilation rather than analyze the 19F signal distribution in static breath-hold 
images. Measuring fractional ventilation requires a wash-in and/or wash-out approach, 
where dynamic imaging is interleaved with breaths of the inhaled gas that provides signal 
contrast (i.e. wash-in) followed by breaths of room air (i.e. wash-out) (2,38,40). 
Therefore, imaging is able to capture the signal enhancement as the inhaled gas washes 
into and out of the lungs. Fractional ventilation can be determined by fitting the resulting 
data to a theoretical model, and then gradients in ventilation are calculated in the vertical 
direction.  
 
It is also important to note that the results of this study might be confounded by B1 
inhomogeneity, which would lead to regional variations in the excitation flip angle. An 


























variations in static breath-hold images (11); however corrections for B1 inhomogeneity 
will not be required for fractional ventilation mapping. Since fractional ventilation 
mapping relies on the breath-to-breath signal changes during wash-in and/or wash-out, 
any regional variations in the baseline signal will not bias the results. Therefore, 
fractional ventilation mapping will provide a robust method for obtaining meaningful 
information regarding ventilation function. 
 
4.4.4 Conclusions 
This proof-of-concept study demonstrates that there is a clear gravitational distribution 
gradient of inert fluorinated gases in human lungs using 19F 3D UTE MRI, and there is a 
potential for this technique to provide functional and regional information regarding lung 
physiology. Future work will explore the measurement of fractional ventilation mapping 
in humans using inert fluorinated gas MRI and a dynamic wash-in/wash-out approach, 
which will provide additional quantitative information related to the distribution of 
ventilation, gas kinetics, and air trapping. Furthermore, imaging in patients with 
pulmonary diseases will help to determine if ventilation gradients measured from 
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5 Fractional Ventilation Mapping using Inert Fluorinated Gas MRI in Rat 
Models of Inflammation and Fibrosis 
Fractional Ventilation Mapping using Inert 
Fluorinated Gas MRI in Rat Models of 
Inflammation and Fibrosis 
 
5.1 Abstract 
Purpose: The purpose of this study was to extend established methods for fractional 
ventilation mapping using 19F MRI of inert fluorinated gases to rat models of pulmonary 
inflammation and fibrosis.  
 
Methods: In this study, 5 rats were instilled with lipopolysaccharide (LPS) in the lungs 
two days prior to imaging, 6 rats were instilled with bleomycin in the lungs two weeks 
prior to imaging, and an additional 4 rats were used as controls. 19F MR lung imaging 
was performed at 3T with rats continuously breathing a mixture of sulfur hexafluoride 
(SF6) and O2. Fractional ventilation maps were obtained using a wash-out approach, by 
switching the breathing mixture to pure O2, and acquiring images following each 
successive wash-out breath.  
 
Results: The mean fractional ventilation (r) was 0.29 ± 0.05 for control rats, 0.23 ± 0.10 
for LPS-instilled rats and 0.19 ± 0.03 for bleomycin-instilled rats. Bleomycin-instilled 
rats had a significantly decreased mean r value compared to controls (p = 0.010). 
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Although LPS-instilled rats had a slightly reduced mean r value, this trend was not 
statistically significant (p = 0.556). Fractional ventilation gradients were calculated in the 
anterior/posterior (A/P) direction, and the mean A/P gradient was -0.005 ± 0.008 cm-1 for 
control rats, 0.013 ± 0.005 cm-1 for LPS-instilled rats, and 0.009 ± 0.018 cm-1 for 
bleomycin-instilled rats. Fractional ventilation gradients were significantly different for 
control rats compared to LPS-instilled rats only (p=0.016). The ventilation gradients 
calculated from control rats showed the expected gravitational relationship, while 
ventilation gradients calculated from LPS- and bleomycin-instilled rats showed the 
opposite trend. Histology confirmed that LPS-instilled rats had a significantly elevated 
alveolar wall thickness, while bleomycin-instilled rats showed signs of substantial 
fibrosis. 
 
Conclusion: Overall, 19F MRI may be able to detect the effects of pulmonary 
inflammation and fibrosis using a simple and inexpensive imaging approach that can 
potentially be translated to humans. 
 
5.2 Introduction 
Interstitial lung disease (ILD) refers to a group of pulmonary disorders that are associated 
with inflammation and fibrosis in the interstitial tissues between the alveoli and capillary 
blood (1). In many cases the cause of ILD is unknown, and the prognosis is generally 
very poor. Animal models play an important role in helping to understand the causes and 
pathophysiology of ILD, and in particular, the instillation of lipopolysaccharide (LPS) 
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and bleomycin in rodent lungs have been established as models that produce 
inflammation that is similar to ILD. LPS is a cell wall component of Gram-negative 
bacteria, and the inflammatory response following LPS inhalation is associated with 
increased levels of neutrophils, cytokines and chemokines (2). Bleomycin is an antibiotic 
derived from Streptomyces verticillus and it has a long history of use as a 
chemotherapeutic agent (3). The inhalation of bleomycin causes an acute inflammatory 
response in the lungs that is followed by fibrosis (4).  
 
Pre-clinical imaging of ILD models can potentially aid in the development of novel 
therapeutics and diagnostic techniques. Conventional proton (1H) magnetic resonance 
imaging (MRI) has been shown to correlate with histology in LPS-instilled rodents, as 
areas of increased signal intensity correspond to a higher tissue density and the presence 
of inflammation (5,6). Similar results have been demonstrated in bleomycin-instilled rats 
(7) and decreases in 1H MRI signal were detected following treatment with a 
glucocorticosteroid (8). Other work has suggested that the product of the 1H signal 
intensity and the T2 value is correlated with collagen content, and is therefore a potential 
biomarker for inflammation and fibrosis (9). The presence of pulmonary inflammation 
can also be detected using hyperpolarized (HP) noble gas MRI, since the injured and 
poorly ventilated regions of the lung appear as signal voids known as ventilation defects 
(10,11). Helium-3 (3He) or xenon-129 (129Xe) is initially polarized using spin-exchange 
optical pumping (SEOP) to enhance the MRI signal by up to 100,000 times above 
thermal equilibrium levels (12). Following inhalation, HP gas MRI is able to provide 
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high resolution images of the gas distribution and quantitative information related to lung 
function (13,14). 
 
HP 129Xe MRI is emerging as a particularly sensitive technique for studying LPS and 
bleomycin-induced inflammation. Following inhalation, xenon readily dissolves into 
blood and tissue, and the large chemical shift range of 129Xe can be exploited to 
separately detect the HP 129Xe in the lung airspaces, barrier tissues, and red blood cells 
(RBCs) (15-17). Time-resolved spectroscopy has been used to demonstrate a reduced 
129Xe RBC signal in bleomycin treated rats (18) and those treated with whole lung 
radiation (19), which was indicative of reduced gas exchange ability due to tissue barrier 
thickening. With the addition of theoretical models, dynamic 129Xe measurements are 
able to detect differences in biomarkers such as the surface to volume ratio (S/V) and gas 
transfer times (20,21). Cleveland et al. recently demonstrated simultaneous imaging of 
the barrier and RBC 129Xe signal in bleomycin treated rats, and the resulting images 
effectively visualized the distribution of fibrotic thickening (22).  
 
Unfortunately, HP 129Xe MRI is a technique that has certain disadvantages, which will 
make translation to routine clinical use difficult. HP 129Xe MRI requires a polarizer and 
isotopically-enriched xenon gas, both of which contribute to large expenses that are 
necessary for imaging. One potential alternative to HP 129Xe for functional lung imaging 
is 19F MRI using inert fluorinated gases (23). Inert fluorinated gas MRI has the 
advantages of using gases that are nontoxic, abundant, and inexpensive compared to HP 
gases. Due to the large gyromagnetic ratio of 19F, there is sufficient thermally polarized 
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signal for imaging at clinical field strengths, and averaging within a single breath-hold is 
possible due to short longitudinal relaxation times. Therefore, the gases do not need to be 
hyperpolarized prior to their use in MRI. Inert fluorinated gas MRI has recently been 
demonstrated in healthy volunteers (24), in patients with pulmonary diseases such as 
chronic obstructive pulmonary disease (COPD) and asthma, and in patients that received 
lung transplants (25).  
 
Although human imaging with inert fluorinated gases is currently in the development 
phase, numerous animal studies have been performed using this technique since 1984 
(26). Inert fluorinated gas MRI studies in animals have explored high resolution 3D 
imaging (27), as well as the measurement of functional biomarkers such as wash-
in/wash-out kinetics (28), dynamic volume measurements (29), apparent diffusion 
coefficients (ADCs) (30,31), and ventilation/perfusion ratios (V/Q) (32,33). Ouriadov et 
al. recently performed a dynamic lung imaging study where fractional ventilation was 
measured using 19F MRI in healthy rats that were ventilated with gas mixtures containing 
sulfur hexafluoride (SF6) or perfluoropropane (C3F8 or PFP) (34). In the present study, 
we hypothesized that a similar dynamic inert fluorinated gas imaging approach would be 
able to detect the effects of inflammation and fibrosis in rat lungs. In order to test this 
hypothesis, rat lung imaging was performed using 19F MRI of SF6 in LPS- and 
bleomycin-instilled rats; fractional ventilation maps and ventilation gradients were 
quantitatively compared between inflammation rats and controls. To our knowledge, 
fractional ventilation mapping has not been previously performed using 19F MRI in an 





5.3.1 Animal Preparation 
This animal study followed specific animal use protocols approved by the local animal 
care committee of Lakehead University and the guidelines set forth by the Canadian 
Council on Animal Care (CCAC). A total of 15 male Sprague Dawley rats (340 ± 31 g, 
Charles River Laboratories, Saint-Constant, Canada) were imaged in this study. 5 rats 
were instilled with a dose of 2.5 mg/kg of LPS in the lungs two days prior to imaging 
(20), while an additional 6 rats were instilled with a dose of 2.5 mg/kg of bleomycin in 
the lungs 14 days (± 1 day) prior to imaging (18). At these time-points, the LPS model 
was expected to produce inflammation, while the bleomycin model was expected to 
produce fibrosis. For intratracheal instillations, the rats were anesthetized using 4.0–5.0% 
isoflurane (Abbott Laboratories, Saint-Laurent, Canada) and then instilled using a gavage 
needle and otoscope. In order to create an even distribution of the instilled agent, the rats 
were gently rotated before being returned to their cages for the prescribed duration. The 
remaining 4 rats were used as controls.  
 
On the day of imaging, rats were initially anesthetized with 2.0–5.0% isoflurane and 60 
mg·kg-1 ketamine (Baxter Corporation, Mississauga, Canada). A 26G catheter (Hospira, 
Lake Forest, IL) was placed in the tail vein and an intravenous injection of 3.0 mg·kg-1 
propofol (Astra Zeneca, Mississauga, Canada) was delivered. Rats remained anesthetized 
by a continuous infusion of a 10:1 mixture of propofol and ketamine in the tail vein at a 
rate of 50 mg·kg-1·h-1. The trachea was exposed by blunt dissection, and a 14G catheter 
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(BD Angiocath, Sandy, UT) was inserted into the trachea through a small incision. Three 
loops of 2-0 silk suture (Surgical Specialties Corporation, Vancouver, Canada) were tied 
around the trachea to ensure an airtight seal. Rats were then ventilated in the supine 
position with a mixture of 80% sulfur hexafluoride (SF6) and 20% O2 using a custom-
built MR-compatible ventilator (35). The breathing rate was set to 60 breaths·min-1 with a 
tidal volume of 8 mL·kg-1 and peak inspiratory pressure (PIP) of 20 cm H2O. Body 
temperature was maintained using a heating pad, and a pulse oximetry sensor was taped 
to the hind paw to monitor blood oxygen saturation and heart rate.  
 
5.3.2 MRI 
All imaging in this study was performed at 3.0 T (Philips Achieva, Best, The 
Netherlands) using a custom-built linear dual-tuned 1H/19F transmit/receive birdcage coil 
(36). Conventional 1H localizer images were initially acquired using a fast spin echo with 
the following settings: TR = 2000 ms, TE = 55 ms, FOV = 75 x 75 mm2, matrix = 256 x 
256, FA = 90°, BW = 370 Hz pixel-1, and 5 averages. Fractional ventilation maps were 
then obtained in the axial plane using the method of Ouriadov et al. (34). The breathing 
protocol for fractional ventilation mapping during the wash-out phase was as follows: 
after at least a 3 minute period of continuous breathing of the SF6/O2 mixture, the SF6 
concentration was assumed to be at a steady state in the lungs and a 10 s breath-hold was 
initiated for the acquisition of a baseline 19F MR image. Breathing was then switched to 
pure O2 for 9 consecutive breaths, and a 12 s breath-hold was initiated following each O2 
breath in order to acquire a series of wash-out images. After the wash-out series was 
complete, breathing was switched back to the SF6/O2 mixture. 
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During each breath-hold, a whole-lung 2D projection 19F MR image was obtained in the 
axial plane using the x-centric pulse sequence (37). 19F MR image acquisition used 
Cartesian sampling with the following settings: TR = 4 ms, TE = 0.48 ms, FOV = 75 x 75 
mm2, matrix = 64 x 64, FA = 70°, BW = 400 Hz pixel-1, 65 averages, and partial echo 
factor = 0.505. Imaging was manually triggered at the beginning of each breath-hold. 
Since only half of k-space was collected during each wash-out series, the entire wash-out 
protocol was repeated using the opposite readout gradient polarity for later combination 
during post processing (34).  
 
5.3.3 Data Analysis 
In order to reconstruct a fully sampled k-space data set, two wash-out series with 
opposite readout gradient polarities were combined. For each line of k-space data in the 
readout direction, the half-echoes were phase corrected, any additional points prior to kx = 
0 were removed, and the two half-echoes were combined into a full echo. Fully sampled 
k-space data sets were then averaged three times. An exponential filter was applied just 
prior to the inverse Fourier transform in order to boost the signal-to-noise ratio (SNR) by 
a factor of approximately two. The baseline images were manually segmented in order to 
separate the lungs from the surrounding background and to create a binary mask, which 
was then applied to all ten images in the wash-out series. The whole-lung SNR was 
measured by dividing the mean signal in the segmented baseline image by the standard 
deviation from a background noise sample.  
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Following image segmentation, ventilation maps were calculated by fitting the final 
wash-out images on a pixel-by-pixel basis in Matlab R2011a (Mathworks, Natick, MA) 
with the following equation (34):  
    nrconstnS  1 , [5-1] 
where S is the available signal at breath number n, and r is the fractional ventilation 
parameter. r is defined as the volume of fresh gas (Vnew) entering a volume at each breath, 












 . [5-2] 
Fractional ventilation gradients were calculated in the anterior/posterior (A/P) direction 
(i.e. the vertical direction) from the resulting r maps in the axial plane. That is, 1D 
profiles were first formed by averaging rows of r map data.  The 1D profiles were then 
fitted with a linear regression, and the slope of the regression yielded the fractional 
ventilation gradient. The mean r values and fractional ventilation gradients were 
compared between groups using a Wilcoxon rank sum test in GraphPad Prism (GraphPad 
Software, La Jolla, CA), where p < 0.05 was considered to be statistically significant. 
 
5.3.4 Histology 
Rats were euthanized at the end of the experiment using pentobarbital sodium (Schering 
Canada, Pointe-Claire, Canada). The rat lungs were excised postmortem and fixed in 
10% neutral buffered formalin for a minimum of 72 hours. Six representative sections 
(upper, middle, and lower in each of the left and right lungs) were extracted and 
embedded in paraffin before being mounted on slides. One set of slides was stained with 
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hematoxylin and eosin (H&E), while another set of slides was stained with Masson’s 
trichrome. The slides were then analyzed using a 40x objective, and representative 
photographs were taken at random locations.  
 
The mean alveolar wall thickness was measured from H&E stains using ImageJ (NIH, 
Bethesda, MD) by overlaying a grid on top of the image and measuring the thickness of 
each alveolar wall crossing. Since collagen appears blue in trichome stains, the amount of 
fibrosis can be quantified by thresholding the image. Trichrome stains were thresholded 
in ImageJ to produce a binary map, and the resulting maps were analyzed in Matlab to 
calculate the percent area that consists of fibrosis (22). The mean alveolar wall 
thicknesses and % fibrosis were compared between groups using a Wilcoxon rank sum 
test in GraphPad Prism, where p < 0.05 was considered to be statistically significant.  
 
5.4 Results 
Figure 5-1 shows representative conventional 1H MR lung images that were obtained in 
the axial plane from a control rat (Rat #4), an LPS-instilled rat (Rat #8), and a bleomycin-
instilled rat (Rat #12). Qualitatively, the 1H images from the control rat and LPS-instilled 
rat appear to be normal, while the 1H image from the bleomycin-treated rat has areas of 




Figure 5-1: Representative conventional 1H lung images obtained in the axial plane from a control rat 
(left), an LPS-instilled rat (middle), and a bleomycin-instilled rat (right). 
 
Figure 5-2 shows three representative series of 2D whole-lung projection 19F wash-out 
images that were obtained in the axial plane from the same rats that were shown in Figure 
5-1. As expected, the baseline 19F images have the highest possible SNR, while the 
subsequent O2 wash-out images have a steadily decreasing SNR. The mean whole-lung 
SNR (± standard deviation) for the baseline images in Figure 5-2 was 19.8 ± 6.2 for the 
control rat, 29.8 ± 8.5 for the LPS-instilled rat, and 14.1 ± 5.6 for the bleomycin-instilled 
rat. In the control rat (Rat #4), the 19F signal was essentially zero by the 5th O2 wash-out 
breath, indicating that the gas in the lungs was completely replaced with O2. For the LPS-
instilled rat (Rat #8), the 19F signal was almost zero by the 6th - 7th wash-out breath, 
indicating that the SF6 washout was slightly slower than in the control rat. For the 
bleomycin-instilled rat (Rat #12), the 19F signal qualitatively appears to wash-out slower 




Figure 5-2: Representative series of 2D whole-lung projection 19F wash-out images obtained in the axial 
plane from a control rat (top row), an LPS-instilled rat (middle row), and a bleomycin-instilled rat (bottom 
row). 
 
Figure 5-3 shows three representative fractional ventilation maps that were obtained from 
the 19F washout images shown in Figure 5-2. The mean r values for the fractional 
ventilation maps shown in Figure 5-3 were 0.32 ± 0.03 for the control rat, 0.31 ± 0.02 for 
the LPS-instilled rat, and 0.15 ± 0.04 for the bleomycin-instilled rat. The error represents 
the standard deviation of the r map, which in turn reflects the heterogeneity of the r map.  
 
Figure 5-3: Representative fractional ventilation maps obtained in the axial plane from a control rat (left), 




Table 5-1 shows the fractional ventilation values calculated for all 15 rats, and these 
results are shown graphically in Figure 5-4. The mean r value for all control rats was 0.29 
± 0.05, while the mean r value for all LPS-instilled rats was 0.23 ± 0.10, and the mean r 
value for all bleomycin-instilled rats was 0.19 ± 0.03.  
 
Figure 5-4: Comparison of mean r values from all rats in this study. The r values were only significantly 
different for bleomycin-instilled rats compared to controls (p = 0.001). 
 
Overall, there was a trend towards decreased r values in LPS-instilled rats compared to 
controls, however, this trend was not statistically significant (p = 0.556). On the other 
hand, the mean r values in bleomycin-instilled rats were significantly decreased 
compared to controls (p = 0.001), but statistically indistinguishable from the LPS-





Table 5-1: Summary of the mean r values and fractional ventilation gradients from all rats in this study. 
Rat 
No. 





1 Control 360 0.27 ± 0.03 -0.00294 ± 0.00003 
2 Control 386 0.34 ± 0.02 -0.00113 ± 0.00003 
3 Control 348 0.24 ± 0.03 -0.01695 ± 0.00005 
4 Control 311 0.32 ± 0.03 0.00089 ± 0.00009 
5 LPS 344 0.12 ± 0.03 0.01168 ± 0.00001 
6 LPS 377 0.28 ± 0.03 0.02082 ± 0.00003 
7 LPS 318 0.12 ± 0.02 0.00809 ± 0.00004 
8 LPS 307 0.31 ± 0.02 0.01115 ± 0.00002 
9 LPS 365 0.32 ± 0.03 0.01572 ± 0.00002 
10 Bleomycin 383 0.21 ± 0.04 -0.02079 ± 0.00008 
11 Bleomycin 296 0.14 ± 0.03 0.02469 ± 0.00003 
12 Bleomycin 344 0.15 ± 0.04 0.01917 ± 0.00002 
13 Bleomycin 343 0.22 ± 0.03 0.02519 ± 0.00003 
14 Bleomycin 295 0.22 ± 0.04 0.00933 ± 0.00005 
15 Bleomycin 319 0.18 ± 0.05 -0.00414 ± 0.00009 
 
Figure 5-5 shows three representative fractional ventilation gradients calculated in the 
A/P (i.e. vertical) direction from a control rat (Rat #3), an LPS-instilled rat (Rat #8), and 
a bleomycin-instilled rat (Rat #12). In the control rat, fractional ventilation decreased as a 
function of vertical distance in the lungs, leading to a negative ventilation gradient. The 
LPS-instilled rat in Figure 5-5 showed the opposite trend, where ventilation increased as 
a function of vertical distance in the lungs and the ventilation gradient was positive. In 
this case, the mean r value from the LPS-instilled rat was slightly higher than the mean r 
value from the control rat. The bleomycin-instilled rat in Figure 5-5 also showed a 
positive ventilation gradient trend, similar to the LPS-instilled rat; however, the intercept 




Figure 5-5: Representative fractional ventilation gradients calculated in the anterior/posterior (A/P) 
direction from a control rat (triangles), an LPS-instilled rat (circles), and a bleomycin-instilled rat 
(diamonds). 
 
Table 5-1 also summarizes the fractional ventilation gradients calculated for all 15 rats in 
this study, and these results are shown graphically in Figure 5-6. Overall, there was a 
statistically significant difference between fractional ventilation gradients calculated from 
control rats compared to LPS-instilled rats (p = 0.016). The mean fractional ventilation 
gradient was -0.005 ± 0.008 cm-1 for control rats, 0.013 ± 0.005 cm-1 for LPS-instilled 
rats, and 0.009 ± 0.018 cm-1 for bleomycin-instilled rats. Although the ventilation 
gradients for bleomycin-instilled rats were generally positive, there was a large variability 
between rats, and therefore the ventilation gradients were not statistically different from 




Figure 5-6: Comparison of A/P ventilation gradients from all rats in this study. The ventilation gradients 
were only significantly different for LPS-instilled rats compared to controls (p = 0.016). 
 
Figure 5-7 shows representative H&E-stained micrographs imaged using a 40x objective 
from a control rat (Rat #1), an LPS-instilled rat (Rat #8), and a bleomycin-instilled rat 
(Rat #12). In this case, the alveolar wall thickness was noticeably thickened compared to 
controls in both the LPS- and bleomycin-instilled rats.  
 
Figure 5-7: Representative H&E-stained micrographs obtained from a control rat (left), and LPS-instilled 





Table 5-2 summarizes the mean alveolar wall thickness for all rats in this study, and these 
results are shown graphically in Figure 5-8. The mean alveolar wall thickness was 5.6 ± 
1.9 μm for control rats, 10.0 ± 2.2 μm for LPS-instilled rats, and 9.1 ± 3.9 μm for 
bleomycin-instilled rats.  
 
 
Figure 5-8: Comparison of the mean alveolar wall thickness from all rats in this study. The alveolar wall 
thickness was significantly different for LPS-instilled rats compared to controls (p = 0.032). 
 
Overall, there was a statistically significant difference between the control and LPS-
instilled rats (p = 0.032). The error associated with the alveolar wall thicknesses in Table 
5-2 represents the standard deviation of measurements in the six representative tissue 
sections. Although the alveolar wall thickness was generally elevated in bleomycin-
instilled rats, the wall thickness was not statistically different from LPS-instilled rats (p = 




Table 5-2: Summary of the mean alveolar wall thickness and fraction of collagen content from all rats in 
this study. 




1 Control 4.6 ± 0.6 0.46 
2 Control 3.4 ± 0.2 0.99 
3 Control 6.7 ± 1.5 0.60 
4 Control 7.5 ± 1.5 1.05 
5 LPS 11.0 ± 2.3 0.69 
6 LPS 12.0 ± 3.1 4.06 
7 LPS 8.8 ± 1.2 1.61 
8 LPS 11.5 ± 4.4 2.31 
9 LPS 6.8 ± 0.5 0.12 
10 Bleomycin 13.5 ± 5.8 19.74 
11 Bleomycin 7.2 ± 0.9 4.16 
12 Bleomycin 14.6 ± 6.4 19.09 
13 Bleomycin 5.8 ± 1.4 6.68 
14 Bleomycin 7.2 ± 12.8 7.56 
15 Bleomycin 6.2 ± 11.2 3.42 
 
Figure 5-9 shows representative trichrome-stained micrographs obtained using a 40x 
objective from a control rat (Rat #3), an LPS-instilled rat (Rat #7), and a bleomycin rat 
(Rat #12). The blue areas in Figure 5-9 indicate that there was substantial fibrosis in the 
bleomycin-instilled rat compared to both the LPS-instilled rat and the control. 
 
Figure 5-9: Representative trichrome-stained micrographs obtained from a control rat (left), and LPS-
instilled rat (middle), and a bleomycin-instilled rat (right) imaged using a 40x objective. 
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Table 5-2 also summarizes the percent area containing fibrosis for all rats in this study, 
and these results are shown graphically in Figure 5-10. The mean area containing 
collagen was 0.77 ± 0.29 % for control rats, 1.8 ± 1.5 % for LPS-instilled rats, and 9.2 ± 
8.1 % for bleomycin-instilled rats. The bleomycin-instilled rats had a significantly greater 
amount of fibrosis compared to both LPS-instilled rats (p = 0.009) and controls (p = 
0.010). On the other hand, the percent area containing fibrosis was not statistically 
different between LPS-instilled rats and controls (p = 0.413). 
 
Figure 5-10: Comparison of the fraction of collagen content for all rats in this study. The collagen content 
was significantly different for bleomycin-instilled rats compared to both LPS-instilled rats (p = 0.009) and 
controls (p = 0.010). 
 
5.5 Discussion 
This study demonstrates for the first time, dynamic 19F MRI of inert fluorinated gases in 
rat models of pulmonary inflammation and fibrosis. Fractional ventilation mapping, 
performed using SF6 in this study, was able to provide quantitative information that was 
related to lung function, and gradients in ventilation were able to provide insight into the 
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regional distribution of ventilation. The mean r values from control rats in this study 
agreed with expectations based on the known ventilator settings and expected lung size 
[TV = 8 mL/kg, FRC = 8 mL, r = TV / (TV + FRC) = 0.25]. The results from control rats 
were also consistent with fractional ventilation mapping techniques that have been 
reported in animals using xenon-enhanced computed tomography (Xe-CT) (39,40), HP 
noble gas MRI (38,41-43), and inert fluorinated gas MRI (34). The mean r values in LPS-
instilled rats were somewhat less than the control rats, but not significantly different from 
the control group. On the other hand, the mean r values in bleomycin-instilled rats were 
less than both the controls and LPS-instilled rats, but only significantly different from the 
control rats. Similarly, reduced fractional ventilation values were observed in a study 
involving fractional ventilation mapping using HP 3He MRI in bleomycin-instilled rats, 
and it was suggested that a decrease in lung compliance was a major factor in 
diminishing alveolar expansion and ventilation (44). 
 
The fractional ventilation gradients from control rats agreed with expectations from the 
literature, where rats in the supine position had a greater ventilation in more dependent 
regions of the lung (34). As discussed in Section 4.4.1, there is a gravitational gradient in 
lung compliance that leads to the well-known gradient in ventilation (45). This 
relationship in ventilation distribution has been previously demonstrated with a variety of 
imaging techniques, such as Xe-CT (40), O2-enhanced 
1H MRI (46), HP noble gas MRI 
(41,47) and inert fluorinated gas MRI (34). The mean fractional ventilation gradients 
from LPS- and bleomycin-instilled rats had a positive slope, and this result might be 
explained by a decrease in lung compliance in dependent regions of the lung due to the 
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presence of inflammation and fibrosis. On the other hand, the variability in the fractional 
ventilation gradients in LPS- and bleomycin-instilled rats may also be explained by 
heterogeneity in the distribution of the instilled agent, which would lead to disruptions in 
normal fractional ventilation gradients.  
 
This work made use of a linear dual-tuned 1H/19F transmit/receive birdcage coil (36), so 
that conventional 1H MRI and inert fluorinated gas MRI could be performed without 
moving the animal. Although, the SNR will theoretically be a factor of √2 less than the 
quadrature 19F birdcage coil used by Ouriadov et al. (34) (assuming all parameters are 
equal), the ability to acquire high quality conventional 1H MR images provides an 
important baseline for comparison. For example, the conventional 1H MR images 
acquired in this study suggested that there was substantial fibrosis throughout the lungs of 
bleomycin-instilled rats; however, these images do not provide information related to 
changes in gas replacement inside the lungs. Furthermore, the conventional 1H MR 
images from the LPS-instilled rats appeared to be very similar to the control rats, insofar 
as there was little 1H signal inside the lungs other than blood vessels. On the other hand, 
fractional ventilation mapping was able to demonstrate changes in ventilation gradients in 
the LPS-instilled rats. Future work will investigate the use of a quadrature dual-tuned 
1H/19F transmit/receive birdcage coil.  
 
It is also interesting to note that the 19F images presented in this study were able to 
visualize the major airways slightly better than the images presented by Ouriadov et al. 
(34), which is likely due to the use of a slightly shorter TE (0.48 ms compared to 0.54 
161 
 
ms). Although an r value close to unity would be expected in the major airways, the 
control rats in this study had an r value of approximately 0.45 in the major airways. 
Ouriadov et al. estimated that the T2* in the major airways was as short as 0.5 ms, while 
the T2* in the lung parenchyma was expected to be approximately 1 ms. Thus, the very 
short T2* explains the relatively poor visualization of the major airways. 
 
The alveolar wall thickness measurements from control rats in this study were similar to 
morphological measurements reported in the literature (48). As expected, the LPS- and 
bleomycin-instilled rats generally had increased alveolar wall thicknesses, which led to 
impaired gas exchange and reduced ventilation. Histological measurements of the 
collagen content confirmed that the bleomycin model produced diffuse fibrosis, 
especially surrounding airways and vessels, whereas after 2 days the LPS model 
produced substantial wall thickening with no noticeable fibrosis. Furthermore, it is 
interesting to note that the fibrosis produced in the bleomycin model led to significant 
changes in fractional ventilation, whereas the inflammation produced in the LPS model 
led to significant changes in ventilation gradients. Future work will determine if 
fractional ventilation mapping can be used to differentiate between inflammation and 
fibrosis. 
 
Fractional ventilation mapping using 19F MRI has potential limitations compared to HP 
129Xe MRI techniques. Since inert fluorinated gases have a very low available 
magnetization compared to HP gases, efficient acquisition strategies, such as x-centric 
(34,37) are required in order to compensate for the low thermally polarized signal. In this 
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study, the use of x-centric imaging provided a short TE and short acquisition window, 
and the final images had minimal blurring and reconstruction artifacts. Since inert 
fluorinated gases have a very low solubility (49), this technique mainly yields 
information related to alveolar ventilation. Although V/Q mapping has been 
demonstrated in animals using T1 mapping of inert fluorinated gases (33), it remains to be 
seen how feasible T1 mapping will be in humans. Therefore, HP 
129Xe MRI may be a 
more sensitive technique for detecting inflammation and ILD due to the ability to probe 
129Xe in the dissolved phase. However, this study demonstrates that changes in lung 
function due to inflammation and fibrosis can be detected using 19F MRI of inert 
fluorinated gases, and this technique is inexpensive compared to HP gases. That is, inert 
fluorinated gases do not require an expensive polarizer, and the source gases cost 
approximately $20 per litre, compared to $200 per litre for enriched 129Xe (50). Other 19F 
MRI techniques have also been used to detect the presence of inflammation induced by 
LPS, such as using injected perfluorocarbons (PFCs) (51). The use of injected PFCs may 
in fact complement the inert fluorinated gas fractional ventilation mapping technique 
used in this study, since the PFCs are able to directly localize the site of inflammation in 
tissue, while the ventilation mapping is able to provide additional quantitative 
information with respect to changes in lung function.  
 
Ventilation mapping has recently been performed in humans using HP 3He MRI, and the 
expected gravitational gradient in fractional ventilation was observed (52). Furthermore, 
altered distributions of fractional ventilation have recently been observed using HP 3He 
MRI in patients cystic fibrosis and asthma (53). It should also be possible to measure 
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fractional ventilation in humans using a 19F MRI technique similar to the animal imaging 
in this study, where dynamic 19F MR imaging is performed during consecutive breaths of 
a fluorinated gas mixture that contains at least 21% O2. Preliminary efforts to quantify 
inert fluorinated gas wash-in and wash-out time constants using 19F MRI are currently 
underway in healthy volunteers and patients with COPD (54,55), and these results appear 
to be promising. Continuing this work will help to determine if fractional ventilation 
mapping obtained using 19F MRI of inert fluorinated gases in humans can provide 
meaningful and functional information regarding lung physiology and the gravitational 
distribution of ventilation in the lungs.  
 
5.6 Conclusion 
Fractional ventilation mapping using 19F MRI of inert fluorinated gases was successfully 
performed in two models of pulmonary inflammation in rats. The detection of reduced 
fractional ventilation and altered ventilation gradients in LPS- and bleomycin-instilled 
rats demonstrates the potential for using inert fluorinated gas MRI to detect the effects of 
inflammation and fibrosis on lung function using a simple and inexpensive approach. The 
fact that an expensive polarizer and scarce noble gas isotopes are not required will make 
clinical translation very attractive. This technique may help to provide clinicians with 
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Due to the significant prevalence of respiratory diseases, such as asthma, COPD, ILD, 
and CF, there is a need in the medical community for new technologies that can 
potentially aid in diagnosis and treatment management. Standard PFTs, such as 
spirometry and plethysmography, lack the regional information that imaging technologies 
are able to provide. Although imaging modalities such as CT, SPECT, and PET are able 
to obtain functional and regional information from the lung, they all use significant levels 
of ionizing radiation, which limits the potential for longitudinal assessment of the lung. 
Conventional 1H MRI is a non-ionizing technique that is able to study lung structure and 
function; however, the image quality has historically been very poor. It is also unclear 
whether indirect 1H-based imaging techniques, such as OE MRI and FD MRI can truly 
measure ventilation in the air spaces of the lung. With HP 3He and 129Xe MRI, it is 
possible obtain a direct measurement of lung function using a completely non-invasive 
and non-ionizing method. Although HP gas MRI has been a successful research tool for 
over 20 years, it may not be implemented into routine diagnostic imaging, since it is a 




19F MRI using inhaled inert fluorinated gases is a relatively new pulmonary imaging 
modality that can potentially provide high quality structural and functional images of the 
lungs. Inert fluorinated gases have the advantages of being nontoxic, abundant, relatively 
inexpensive, and the technique can be performed on any MRI scanner with broadband 
imaging capabilities. Therefore, inert fluorinated gas MRI has the potential to be 
clinically adopted as a pulmonary imaging modality that can aid in disease diagnosis. 
Inert fluorinated gas MRI of the lungs has been performed extensively in animals since 
the 1980s, and the measurement of various functional biomarkers has been demonstrated, 
such as ADC, fractional ventilation, wash-in/wash-out kinetics, and V/Q. Preliminary 
work in the lungs of healthy volunteers and patients with lung diseases has been reported 
recently, and improvements in image quality are ongoing. This thesis reports inert 
fluorinated gas MR imaging in healthy human volunteers and in animal models of 
pulmonary disease. Various imaging techniques were introduced, including static breath-
hold ventilation imaging and preliminary measurements of functional image-derived 
biomarkers.  
 
6.2 19F MRI Developments in Thunder Bay, Ontario 
Chapter 2 discussed an initial feasibility study involving inert fluorinated gas imaging in 
healthy volunteers (1). Since initial reports of 19F MRI in human lungs had a very poor 
image quality, it was hypothesized that a UTE approach would help to overcome the very 
short relaxation times of inert fluorinated gases. Thus, a 19F UTE acquisition was 
optimized, and imaging was performed in a group of 10 healthy volunteers. In addition, 
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this work compared the image quality from two different gas breathing techniques: a 
single 1 L bolus inhalation that is commonly used for HP gas MRI, and continuous 
breathing from a large fluorinated gas reservoir. As expected, the continuous breathing 
method allowed for a greater 19F spin density in the lungs, and hence a significantly 
improved image quality. Overall, the SNR from the optimized UTE approach and 
continuous breathing was a factor of about two times higher than previous results in the 
literature (2). 
 
Since inert fluorinated gas MRI is still being developed and optimized, the work to date 
has reported stand-alone studies that used different techniques, different hardware, and 
different imaging parameters. Thus, the literature lacks quantitative comparisons between 
different types of 19F image acquisitions. Chapter 3 discussed a quantitative comparison 
of inert fluorinated gas MR imaging that was performed in a group of 5 healthy 
volunteers using both UTE and gradient echo imaging (3). Although SNR from UTE 
imaging was significantly higher than gradient echo imaging, the UTE images suffered 
from blurring and poorly defined edges. These results were confirmed with similar 
imaging performed in a resolution phantom. Overall these data will help to guide future 
developments in 19F MRI and the choice of pulse sequence parameters to be used in 
future imaging studies. 
 
In addition to static breath-hold ventilation imaging, inert fluorinated gas MRI can 
potentially provide image-derived biomarkers that can yield insight into lung function 
and disease severity. Chapter 4 discussed initial efforts to quantify imaging biomarkers 
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using inert fluorinated gas MR images obtained in healthy volunteers. Ventilation defect 
measurements can provide indicators of airway obstruction, and a preliminary 
comparison to HP 3He MR imaging suggested that ventilation defect volumes were 
indistinguishable between the two techniques (4). The ADC is a biomarker for 
microstructural changes in the lungs, and preliminary 19F ADC maps were presented for a 
single healthy volunteer (5). Finally, gravitational gradients in ventilation are expected 
based on known patterns in lung physiology, and preliminary 19F MRI measurements of 
gravitational gradients were presented for 6 healthy volunteers (5,6).  
 
In order to demonstrate the potential of inert fluorinated gas MRI for detecting 
pulmonary diseases, it is worthwhile to pilot novel imaging biomarker measurements in 
animal models. Chapter 5 discussed inert fluorinated gas fractional ventilation mapping 
that was performed in rat models of inflammation and fibrosis (7). Fractional ventilation 
maps were obtained using an established dynamic wash-out imaging technique (8), and 
the results were compared between controls and rats that were instilled with LPS or 
bleomycin. There was a trend towards decreased ventilation values in LPS- and 
bleomycin-instilled rats, and these rats also had substantially different patterns of 






6.3 Future Work 
 
6.3.1 Reproducibility and Validation 
As researchers consider the potential clinical implementation of inert fluorinated gas 
MRI, rigorous reproducibility and validation studies will be required. For example, 
various studies have established the reproducibility of HP 3He MRI in COPD (9), CF (10) 
and in exercise-induced bronchoconstriction (11). One preliminary study at Duke 
University has demonstrated a reasonable reproducibility for inert fluorinated gas MR 
imaging in patients with asthma (12). Future work will evaluate the reproducibility of 
inert fluorinated gas MRI in larger cohorts, including both healthy individuals, as well as 
patients with various respiratory diseases.  
 
Since 129Xe has emerged as the preferred HP gas in recent years, quantitative 
comparisons between PFTs, CT, HP 3He MRI, and HP 129Xe MRI have helped to 
establish the clinical relevance of HP 129Xe imaging (13,14). Furthermore, these 
quantitative validation studies can help researchers to understand how differences in the 
physical properties of the gases relate to differences in the measured biomarkers. Since 
SF6 and PFP are both heavier than Xe, similar comparison studies will be required to help 
validate inert fluorinated gas MRI. Although the preliminary results presented in this 
thesis comparing 19F MRI and HP 3He MRI appear to be promising (Section 4.2), more 





6.3.2 Hardware Improvements 
In general, the image SNR is a function of many variables, including spin density, 
relaxation, hardware, and pulse sequence parameters. Since the human imaging presented 
in this thesis used flexible coils shaped like a life vest, the coil design may have 
contributed to inhomogeneities in the excitation flip angle. Therefore, future 
quantification of image-based biomarkers will require corrections for B1 
inhomogeneities, and similar techniques have already been characterized for HP gas MRI 
(15). Alternatively, the application of novel RF coil designs may help to provide an 
improved SNR as well as more robust measurements of functional biomarkers. For 
example, Dregely et al. recently reported a 129Xe coil that included a phased-array 
receiver and an asymmetric birdcage transmit coil (16). The asymmetric birdcage 
transmit coil maximizes space inside the scanner bore while providing a uniform B1 
excitation homogeneity. The 32-channel phased-array receive coil provides the SNR 
benefits of combining data many small coil elements that individually have a very high 
SNR (17).  
 
The animal imaging presented in Chapter 5 made use of a linear dual-tuned 1H/19F 
birdcage RF coil (18). The purpose of using a dual-tuned RF coil was so that 
conventional 1H localization and inert fluorinated gas imaging could be performed 
without moving the animal to change RF coils. Thus, the resulting 1H and 19F lung 
images will be perfectly co-registered. Likewise, the use of dual frequency coils might 
also allow for a more accurate comparison of HP 3He, HP 129Xe, and inert fluorinated gas 
imaging in humans. A dual-tuned 129Xe/3He RF coil has been recently reported for 
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simultaneous 1H, 3He, and 129Xe imaging during a single breath-hold (19). Since the 
resonance frequency of 19F is relatively close to the frequencies of 3He and 1H (see Table 
1-1), it remains to be seen what dual-tuned coil designs will be possible. 
 
Since inert fluorinated gases are used in numerous industrial applications, atmospheric 
concentrations of these gases have been increasing in recent decades. Furthermore, 
fluorinated gases are known to be potent greenhouse gases with long lifetimes (20). 
Therefore, efforts will be made to capture and recycle the exhaled fluorinated gases. For 
example, the MR-compatible gas delivery system reported by Halaweish et al. was 
designed to use a non-rebreathing valve that isolates the inspiratory and expiratory gases, 
so that the exhaled gases can be collected in a large reservoir (21). Similarly, the high 
cost of 3He has motivated the development of devices that can capture 3He gas and purify 
it after an imaging experiment (22).  
 
6.3.3 Pulse Sequence Improvements 
Various accelerated image acquisition techniques have been reported for HP 3He MRI, 
such as parallel imaging (23) and compressed sensing (24). In essence, these techniques 
undersample the data acquisition such that spatial and/or temporal redundancies in the 
acquired data can be exploited to reconstruct the correct image. HP 3He has the advantage 
of having an initially very large available magnetization that can be manipulated to obtain 
high quality accelerated images despite undersampling. Since inert fluorinated gases have 
a much lower available magnetization than HP gases, it remains to be seen how much of 
an advantage accelerated acquisition techniques can offer. Parallel imaging with inert 
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fluorinated gases will likely be explored in conjunction with the development of phased-
array coil designs (25). 
 
The use of a computer-controlled gas delivery system may also help improve the 
robustness of inert fluorinated gas images by gating long acquisitions. If the image 
acquisition is longer than a breath-hold, then data can be acquired over multiple 
respiratory cycles and the gas delivery system could trigger the acquisition so that data is 
only acquired during a particular portion of the respiratory cycle (21). A number of other 
gating methods have been successfully demonstrated for 1H-based lung MRI, including 
the use of a respiratory bellows (26), navigator signals (27), or direct current (DC) signals 
from coil elements near the diaphragm (28). Although this thesis focused on developing 
optimized imaging techniques for 10 – 25 second breath-holds, the true power of inert 
fluorinated gas MRI may be realized by imaging during continuous breathing. Longer 
acquisitions will enable inert fluorinated gas lung imaging with a higher SNR and higher 
resolution. 
 
Since pulmonary MR imaging is typically performed during a breath-hold, it is extremely 
difficult to perform repeated imaging at a consistent lung inflation state. Any errors in the 
inhaled lung volume will result in a change in the apparent lung size and gas distribution. 
Therefore, it may be extremely difficult to accurately compare conventional 1H MRI and 
inert fluorinated gas MRI for the measurement of ventilation defects. For this reason, the 
human volunteers imaged in this thesis were coached to hold their breath at 
approximately FRC + 1 L for imaging. The use a computer-controlled gas delivery 
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system may help to alleviate issue by recording inhaled gas volumes; however, another 
approach might be to perform simultaneous 1H and 19F imaging following an inert 
fluorinated gas breath-hold. Simultaneous imaging of 1H and HP 3He lung imaging has 
been previously demonstrated, and it allows for a perfect co-registration of the 
anatomical information from conventional 1H MRI and the functional information 
provided by HP 3He MRI (29).  
 
6.3.4 Functional Imaging 
Dynamic imaging during continuous breathing of a mixture of inert fluorinated gas and 
O2 can potentially provide physiologically meaningful indicators of lung function, such 
as wash-in/wash-out kinetics, fractional ventilation, and air trapping. The dynamic wash-
out imaging technique presented in Chapter 5 could easily be translated to clinical 
imaging, as similar techniques have been reported in humans using HP 3He imaging (30). 
Dynamic imaging using HP gases is challenging, since the HP magnetization has a finite 
lifetime, and polarizers typically have limited production rates. Inert fluorinated gases, on 
the other hand, are not subject to such restrictions. Preliminary reports of dynamic 
imaging in humans using inert fluorinated gas MRI have been presented at scientific 
meetings (31-33), and future work using optimized acquisition strategies will help to 
refine these techniques. 
 
Pre-clinical imaging of animal models has been recognized as an important step in drug 
development, since imaging can provide functional biomarkers that relate to disease 
severity (34). Thus, inert fluorinated gas imaging of animal models will remain important 
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for the development of novel biomarkers as well as for validating biomarkers that have 
previously been established using HP gas MRI. Future work will likely continue to 
prototype novel pulse sequences (8), as well as improve dynamic imaging techniques (7), 
ADC measurements (35) and S/V ratio measurements (36). This work will help to refine 
novel inert fluorinated gas imaging techniques prior to clinical implementation. 
 
6.4 Outlook 
Although the first inert fluorinated gas images reported by Heidelberger and Lauterbur 
were extremely primitive, it was recognized in their 1982 abstract that gas phase MRI 
could potentially become an important component of pulmonary imaging technology 
(37). That statement still rings true today, as HP noble gas and inert fluorinated gas 
technology continues to evolve. The same group that originally co-pioneered HP noble 
gas MRI in 1994 is now helping to develop the next pulmonary imaging modality: inert 
fluorinated gas MRI. Once fully optimized, this technique may have a significant 
advantage over HP noble gas MRI, since it is inexpensive, the gases are abundant, and an 
expensive polarizer is not required. All of these developments and advantages may help 
lead to Health Canada regulatory approval for clinical imaging using inert fluorinated gas 
MRI.  
 
Since this is a very new pulmonary imaging modality that is still under development, 
only healthy volunteers were imaged in this thesis. Dr. Mitchell Albert’s research group 
at TBRRI  is currently seeking regulatory approval to perform inert fluorinated gas MR 
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imaging in patients with pulmonary diseases, such as COPD, asthma, lung cancer, lung 
transplants, mesothelioma, pulmonary embolism, ILD, and CF. Although inert 
fluorinated gas MRI has already been performed in patients with pulmonary diseases at 
Duke University, the reported imaging quality has been relatively poor, and there is a 
lack of quantitative functional data (2). Therefore, continued imaging in patients with 
pulmonary diseases will help to determine if inert fluorinated gas MRI can provide 
diagnostic information that is relevant and clinically meaningful. 
 
Pulmonary inert fluorinated gas MRI can potentially help to address the 
disproportionately high rates of obstructive lung diseases in aboriginal populations. For 
example, aboriginals are 1.41 times more likely to have asthma (38) and up to 2.4 times 
more likely to have COPD (39) than non-aboriginals. There are a number of strong risk 
factors for obstructive lung diseases that are particularly prevalent in First Nations 
communities, such as smoking, second-hand smoke, and biomass burning. Therefore, the 
development of inert fluorinated gas MRI will provide a substantial benefit to aboriginal 
communities, since it is a technique that can provide many critical indicators of lung 
function, thereby providing insight into the burden of obstructive lung diseases. TBRRI is 
also uniquely situated, since it has access novel lung imaging technologies, and there is a 






This thesis has presented a number of exciting developments in inert fluorinated gas MR 
imaging, including static breath-hold ventilation imaging and a number of image-derived 
biomarkers that may be important in detecting and understanding respiratory diseases. 
Inert fluorinated gas MRI can potentially provide functional lung information that is 
similar to HP 3He and 129Xe MRI, but without the need for scarce isotopes and expensive 
polarizer equipment. Overall, interest in pulmonary 19F MRI of inert fluorinated gases is 
increasing, and numerous sites around the world are now interested in developing this 
technique. The ongoing improvements in image quality will allow for the continued 
investigation of novel and robust functional biomarkers, such as ADC, S/V, and 
fractional ventilation. Overall, inert fluorinated gas MRI has the potential to become a 
viable clinical imaging modality for non-invasively imaging the lung and for providing 
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